{"study_id": 33514, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the regulatory effects of Pterostilbene (PTE) on cell survival, drug resistance, and invasion in SUN-resistant renal cell carcinoma (RCC) cells.", "results_summary": "PTE induced apoptosis by upregulating the Bax/Bcl-2 ratio, increased SUN sensitivity by inhibiting RLIP76, reduced cell invasion, and downregulated MMP expression. It also suppressed the Ras/ERK and Akt/mTOR pathways.", "population_specificity": "SUN-resistant 786-O renal cell carcinoma cells (in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:12.083680+00:00"}
{"study_id": 33515, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Pterostilbene (PTE) improves sleep restriction-induced metabolic disorders and its relationship with the circadian clock.", "results_summary": "PTE significantly improved glucose and lipid metabolism, enhanced circadian behavior, and restored the circadian rhythm of liver clock and metabolic output genes in sleep-restricted mice. Molecular docking suggested PTE interacts with ROR\u03b3, potentially modulating Bmal1 transcription to maintain metabolic rhythm.", "population_specificity": "Male C57/B6J mice subjected to sleep restriction.", "effective_dosage": "50, 100, or 200 mg/kg\u00b7bw/d PTE.", "study_duration": "Five consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:12.451287+00:00"}
{"study_id": 33512, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pterostilbene (PTE) could mitigate obesity-induced depression (OID) in mice by addressing insulin resistance, neuroinflammation, and hypothalamic-pituitary-adrenal axis dysfunction.", "results_summary": "PTE-treated mice showed reduced body weight, depression-like behavior, and improved metabolic markers (insulin resistance, lipid profile, antioxidant enzymes, inflammatory cytokines). PTE also restored brain and adipose tissue architecture and upregulated SIRT1-mediated leptin-ghrelin signaling.", "population_specificity": "Adolescent Swiss albino male mice fed a cafeteria diet (CD) to induce obesity and depression.", "effective_dosage": "10, 20, 40 mg/kg", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:12.452701+00:00"}
{"study_id": 33517, "supplement_id": 1484, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the anti-myeloma activity and immunomodulatory effects of DCZ0825, a derivative of pterostilbene, in multiple myeloma (MM) cells.", "results_summary": "DCZ0825 demonstrated direct anti-myeloma activity by inducing apoptosis and cell cycle arrest in MM cells, while also reversing immunosuppression by promoting M1 macrophage transformation and enhancing immune cell activity. It increased positive regulatory cells (CD4T, CD8T, NK cells) and decreased negative regulatory cells (Treg, MDSCs).", "population_specificity": "Multiple myeloma (MM) cells and associated immune cells in vitro.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:13.060011+00:00"}
{"study_id": 33518, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anticancer effects of PTER-ITC on human osteosarcoma MG-63 cells, focusing on its ability to inhibit survival, proliferation, and migration, and its underlying molecular mechanisms.", "results_summary": "PTER-ITC inhibited osteosarcoma cell survival, proliferation, and migration, induced apoptosis, and reversed epithelial-mesenchymal transition by modulating key proteins and disrupting the \u03b2-catenin/TCF-4 interaction.", "population_specificity": "Human osteosarcoma MG-63 cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:13.327699+00:00"}
{"study_id": 33521, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pterostilbene (PTS) regulates Nrf2 in diabetic wounds and triggers a pro-wound healing response mediated by macrophages.", "results_summary": "PTS attenuated fibroblast migration, \u03b1-SMA, and HIF1\u03b1 levels, rescued impaired wound closure in diabetic mice, and improved inflammatory markers and Nrf2 response, comparable to the standard treatment Regranex.", "population_specificity": "Diabetic mice with impaired wound healing.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:19.613047+00:00"}
{"study_id": 33519, "supplement_id": 1484, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to design and synthesize novel pterostilbene derivatives with high anti-inflammatory activity and low toxicity, and evaluate their efficacy in treating acute colitis.", "results_summary": "Compound 8, a pterostilbene derivative, showed strong anti-inflammatory activity (IC50 = 0.6 \u03bcM against NO) by inhibiting the NF-\u03baB/MAPK pathway and effectively alleviated DSS-induced acute colitis in mice with good safety in acute toxicity experiments.", "population_specificity": "LPS-treated RAW 264.7 cells and DSS-induced acute colitis in mice.", "effective_dosage": "Not specified for pterostilbene; compound 8 tested at IC50 = 0.6 \u03bcM in vitro.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:20.647175+00:00"}
{"study_id": 33520, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine whether Ptd-1 (a derivative of Pterostilbene) could alleviate vascular calcification in mouse models and human aortic smooth muscle cells.", "results_summary": "Ptd-1 significantly reduced atherosclerosis progression, intimal and medial calcification, lipid deposition, and calcium salt deposition in mice. It also attenuated inflammatory factors (IL-1\u03b2, TNF\u03b1, IL-6) and disrupted ERK1/2 and \u03b2-catenin signaling pathways.", "population_specificity": "ApoE-deficient mice, wild-type mice, and human aortic smooth muscle cells (HASMCs).", "effective_dosage": "Not specified", "study_duration": "12/16 weeks for mice", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:20.689146+00:00"}
{"study_id": 33526, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the distribution of pterostilbene in ischemic rat brains and explore its potential mechanisms in treating cerebral ischemia-reperfusion injury.", "results_summary": "Pterostilbene significantly restored cerebral microcirculation, reduced infarct volume, improved neurological function, and ameliorated neuronal damage in ischemic rats. It also restored energy supply, rebalanced neurotransmitters, and reduced abnormal polyamine accumulation and phospholipid metabolism.", "population_specificity": "Ischemic rats", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:21.657911+00:00"}
{"study_id": 33524, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Pterostilbene could reduce neuroinflammation and brain injury after intracerebral hemorrhage (ICH) in mice and explore its underlying molecular mechanisms.", "results_summary": "Pterostilbene improved neurological behavior, reduced lesion volume and neural apoptosis, alleviated blood-brain barrier damage and brain edema, and suppressed neuroinflammation and microglial proinflammatory activities by promoting mitochondrial fusion via OPA1 upregulation.", "population_specificity": "Mice with collagenase-induced intracerebral hemorrhage (ICH).", "effective_dosage": "10 mg/kg, administered once daily via intraperitoneal injection.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:21.859086+00:00"}
{"study_id": 33523, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the protective mechanisms, pharmacokinetics, and safety of pterostilbene in in vitro and in vivo models of CNS disorders to assess its potential therapeutic effects.", "results_summary": "Pterostilbene demonstrated protective effects in CNS disorders through mechanisms like antioxidant and anti-inflammatory activity, regulation of lipid metabolism, improvement of synaptic function, and inhibition of glioma cell migration. Possible molecular targets included AMPK/STAT3, Akt, NF-\u03baB, MAPK, and ERK signaling pathways.", "population_specificity": "In vitro and in vivo models of CNS disorders (not specified for humans).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:21.924825+00:00"}
{"study_id": 33525, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the molecular mechanisms behind pterostilbene's neuroprotective effects against cerebral ischemia/reperfusion (I/R) injury.", "results_summary": "Pterostilbene reduced cerebral infarction volume, improved neurological deficits, enhanced cerebral microcirculation, and stabilized the blood-brain barrier (BBB) by targeting MMP-9 and modulating the Wnt pathway. It also maintained endothelial cytoskeleton integrity and extracellular matrix stability during early and late stages of I/R injury.", "population_specificity": "In vivo models (middle cerebral artery occlusion) and in vitro models (oxygen-glucose deprivation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:22.130282+00:00"}
{"study_id": 33527, "supplement_id": 1484, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the antiadipogenic and antiobesogenic efficacy of pterostilbene in 3T3-L1 adipocyte cells.", "results_summary": "Pterostilbene reduced lipid accumulation in adipocyte differentiation, improved spindle-like morphology, and increased Glut-4 and adiponectin levels without significant cytotoxicity at concentrations \u22647.5 \u00b5M.", "population_specificity": "3T3-L1 adipocyte cells (in vitro study).", "effective_dosage": "5 \u00b5M and 7.5 \u00b5M.", "study_duration": "Up to 14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:28.107442+00:00"}
{"study_id": 33511, "supplement_id": 1484, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to explore the protective effect and potential mechanism of PS-GA-RGD nanomedicine on dry eye disease in vitro and in vivo.", "results_summary": "PS-GA-RGD demonstrated significant anti-inflammatory and antioxidant effects, reduced ROS and NLRP3 inflammasomes, and enhanced cellular uptake and corneal retention, showing superior efficacy compared to unmodified PS. It also prevented corneal epithelial cell defects and apoptosis while protecting conjunctival goblet cells.", "population_specificity": "Murine macrophages (RAW 264.7), human corneal epithelial cells, and experimental dry eye animal models (rabbits).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:28.915362+00:00"}
{"study_id": 33529, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pterostilbene (PTE) could mitigate diabetes-induced depression-like behavior in male Wistar rats with type 2 diabetes mellitus (T2DM).", "results_summary": "PTE significantly reduced depressive-like behavior, improved glucose tolerance, reduced insulin resistance, lowered cortisol and inflammatory markers, and enhanced SIRT1 gene expression. It also restored blood glucose, lipid profiles, and organ morphology.", "population_specificity": "Male Wistar rats with T2DM induced by nicotinamide and streptozotocin.", "effective_dosage": "10, 20, and 40 mg/kg, orally.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:29.557581+00:00"}
{"study_id": 33533, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to improve the aqueous solubility of pterostilbene (PTB) using modified cyclodextrins (CDs) to enhance its potential for medicinal applications.", "results_summary": "The study successfully formed inclusion complexes of PTB with various CDs, significantly enhancing its solubility by 700-fold to 1250-fold. Complexation was confirmed in both solid-state and aqueous solutions, with association constants ranging from 15,000 to 55,000 M-1.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:30.362322+00:00"}
{"study_id": 33528, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the anti-obesity effects of pterostilbene and resveratrol, focusing on their mechanisms, including thermogenic activation and lipid metabolism alteration.", "results_summary": "The study suggests pterostilbene and resveratrol may aid weight loss by increasing metabolic rate, thermogenesis, and altering lipid metabolism, with potential in obesity prevention and treatment. However, optimal dosage, long-term safety, and mechanisms require further investigation.", "population_specificity": "Obese individuals (general, not specified further).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:30.614294+00:00"}
{"study_id": 33530, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to design and evaluate novel pterostilbene derivatives for their antioxidant and anti-inflammatory effects, particularly in treating heart failure.", "results_summary": "Compound E1, a pterostilbene dihydropyrazole derivative, showed potent anti-inflammatory and antioxidant activities by inhibiting NF-\u03baB signaling and enhancing Nrf2-mediated antioxidant enzyme expression, improving doxorubicin-induced heart failure in mice.", "population_specificity": "RAW264.7 cells, H9C2 cells, and a mouse model of heart failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:30.651420+00:00"}
{"study_id": 33532, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether pterostilbene (Pte) could mitigate oxidative stress and neurological dysfunction induced by chronic intermittent hypoxia (CIH) in mice.", "results_summary": "Pterostilbene improved neurological function, reduced oxidative stress markers (MDA), enhanced antioxidant enzymes (SOD, GSH-PX), modulated immune responses (Th2/Treg upregulation, Th1/Th17 downregulation), and inhibited gliocyte activation via p-ERK signaling to protect nerve cells.", "population_specificity": "CIH-induced mouse model (not human subjects).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:31.114218+00:00"}
{"study_id": 33531, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of novel Pterostilbene-loaded solid lipid nanoparticles (CS/Lf/PTS-SLNs) as a targeted therapy for breast cancer, focusing on overcoming solubility, bioavailability, and stability limitations.", "results_summary": "CS/Lf/PTS-SLNs demonstrated superior cytotoxicity, anti-migratory effects, and cellular uptake compared to PTS-solution, achieving a 2.4-fold decrease in tumor growth in vivo and enhanced molecular suppression of VEGF, cyclin D1, and upregulation of caspase-3 and BAX.", "population_specificity": "Triple-negative MDA-MB-231 breast cancer cells and an orthotopic cancer model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:31.628046+00:00"}
{"study_id": 33534, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the miR-21-modulatory potential of PTER-ITC in drug-resistant breast cancer cell lines to assess its therapeutic potential.", "results_summary": "PTER-ITC effectively reduced survival of drug-resistant breast cancer cells by inducing apoptosis, inhibiting migration and invasiveness, and significantly downregulating miR-21 expression while upregulating tumor suppressor genes.", "population_specificity": "Tamoxifen-resistant MCF-7 and 5-fluorouracil-resistant MDA-MB 231 breast cancer cell lines.", "effective_dosage": "IC50 values: 37.21 \u00b5M for TR/MCF-7, 47.00 \u00b5M for 5-FUR/MDA-MB 231.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:37.186643+00:00"}
{"study_id": 33538, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate Pterostilbene's inhibitory effect on inflammation-associated tumor metastasis and explore its underlying mechanisms.", "results_summary": "Pterostilbene reduced lung metastasis, decreased proinflammatory cytokines (TNF-\u03b1 and IL-6), inhibited neutrophil elastase activity, and prevented TSP-1 degradation, thereby suppressing tumor cell migration and reversing EMT marker expression.", "population_specificity": "Mice with LPS-induced lung inflammation and melanoma metastasis.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:37.858378+00:00"}
{"study_id": 33539, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the metabolic impact of pterostilbene supplementation on liver metabolism in Wistar rats with induced liver steatosis.", "results_summary": "Pterostilbene supplementation altered the metabolism of vitamins and derivatives, among other metabolites, in rats with liver steatosis, demonstrating distinct effects compared to resveratrol. The study highlighted 34 metabolites affected by the different diets, with ion mobility separation aiding in metabolite identification.", "population_specificity": "Wistar rats with induced liver steatosis fed a high-fat and high-fructose diet.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:38.600674+00:00"}
{"study_id": 33535, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the chemopreventive effects of pterostilbene (PS) and a probiotic (PRO) on colorectal cancer precursor lesions in a rat model of intestinal carcinogenesis induced by 1,2-DMH.", "results_summary": "PRO alone and PRO combined with PS were the most effective interventions in improving several parameters of 1,2-DMH-induced colorectal carcinogenesis, suggesting potential preventive benefits.", "population_specificity": "Male Wistar rats", "effective_dosage": "300 ppm in diet ad libitum", "study_duration": "15 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:38.667151+00:00"}
{"study_id": 33536, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Pterostilbene (PTN) on atopic dermatitis (AD) in mice, focusing on inflammation, oxidative stress, and cytokine levels.", "results_summary": "PTN reduced ear weight, skin thickness, thymus and spleen size, IgE levels, and inflammatory cells in diseased mice. It also decreased oxidative stress markers and inflammatory cytokines (IL-4, IL-6, TNF-\u03b1, NF-\u03baB) in the skin.", "population_specificity": "Mice with DNCB-induced atopic dermatitis.", "effective_dosage": "0.2%, 0.6%, and 1% w/w applied topically daily.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:39.097532+00:00"}
{"study_id": 33537, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect and underlying mechanism of pterostilbene on oxidative damage in ovarian granulosa cells.", "results_summary": "Pterostilbene improved cell viability, reduced oxidative stress, and inhibited ferroptosis in ovarian granulosa cells exposed to H2O2. It upregulated Nrf2 transcription via histone acetylation, and Nrf2 inhibition reversed its therapeutic effects.", "population_specificity": "Ovarian granulosa cell lines COV434 and KGN.", "effective_dosage": "Different concentrations (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:39.208678+00:00"}
{"study_id": 33541, "supplement_id": 1484, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to reduce the toxicity of a pterostilbene derivative (compound 32) while maintaining its biological activity, particularly its anti-inflammatory effects.", "results_summary": "Compound D22, a novel pterostilbene derivative, demonstrated low toxicity and potent inhibitory efficacy against IL-1\u03b2 production (IC50 = 2.41 \u03bcM) and NLRP3 inflammasome activation, showing significant therapeutic effects in a mouse model of acute colitis.", "population_specificity": "DSS-induced acute colitis mouse models.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:39.699722+00:00"}
{"study_id": 33543, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether pterostilbene (PTS) could alleviate hemin-mediated suppression of Nrf2 activation and M2 macrophage polarization, potentially offering therapeutic benefits for diabetic foot ulcers (DFU).", "results_summary": "PTS reversed hemin-induced suppression of Nrf2 activation and its downstream targets, restored M2 macrophage polarization, reduced proinflammatory responses, and lowered MMP2 expression under hyperglycemic conditions. Proteomic analysis also showed PTS suppressed cellular stress and inflammation markers.", "population_specificity": "IC-21 macrophages studied under normoglycemic and hyperglycemic conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:46.266931+00:00"}
{"study_id": 33542, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the influence of pterostilbene on the proliferation and apoptosis of human melanoma cells, specifically amelanotic (C32) and melanotic (A2058) cell lines.", "results_summary": "Pterostilbene reduced the proliferation of both amelanotic and melanotic melanoma cells and induced apoptosis in amelanotic C32 cells via increased expression of BAX, CASP9, and CASP3 genes, caspase 3 activity, and DNA degradation. However, it did not activate apoptosis in the A2058 cell line.", "population_specificity": "Human melanoma cells (C32 and A2058 cell lines)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:46.425318+00:00"}
{"study_id": 33547, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the therapeutic effect of pterostilbene on experimental pulmonary fibrosis, diabetes, and myocardial infarction, focusing on oxidative damage pathways.", "results_summary": "Pterostilbene significantly upregulated SOD and GSH levels while downregulating MDA levels, demonstrating effectiveness in improving oxidative damage-related conditions compared to control groups.", "population_specificity": "Animal models with experimental pulmonary fibrosis, diabetes, and myocardial infarction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:46.586839+00:00"}
{"study_id": 33546, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Pterostilbene (PTE) could alleviate Fumonisin B1 (FB1)-induced cytotoxicity in porcine alveolar macrophages.", "results_summary": "PTE largely recovered FB1-induced cytotoxicity, apoptosis, pro-inflammatory cytokine production, and mitochondrial damage by inhibiting the JAK/STAT signaling pathway, specifically targeting JAK2 and STAT3 genes.", "population_specificity": "Porcine alveolar macrophages (3D4/21 cell line).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:46.788345+00:00"}
{"study_id": 33545, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether pterostilbene could inhibit HCMV replication and elucidate its mechanism of action.", "results_summary": "Pterostilbene inhibited HCMV replication, reduced viral protein expression and DNA replication, and suppressed cellular senescence biomarkers. It primarily acted post-viral entry, with an IC50 of 1.315 \u03bcM and a selectivity index of 26.73.", "population_specificity": "Human diploid fibroblast WI-38 cells infected with HCMV Towne strain.", "effective_dosage": "1.315 \u03bcM (half-maximal inhibitory concentration)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:47.391111+00:00"}
{"study_id": 33544, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether pterostilbene could alleviate oxaliplatin-induced peripheral neuropathy (OIPN) and explore its potential mechanisms, including its combination with celecoxib.", "results_summary": "Pterostilbene effectively reduced neuropathic pain and motor impairments, restored histopathological changes, and attenuated inflammation, oxidative stress, and apoptosis markers. The combination with celecoxib showed comparable or enhanced relief of neuropathic pain.", "population_specificity": "Rats (animal study)", "effective_dosage": "40 mg/kg/day, orally for 5 weeks", "study_duration": "5 weeks", "interactions": "Celecoxib (30 mg/kg/day) was studied in combination, but no other interactions were mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:47.927387+00:00"}
{"study_id": 33548, "supplement_id": 1484, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic effects and safety of PEGylated pterostilbene micelles (PTENPs) in treating inflammatory bowel disease (IBD) and explore its potential mechanisms.", "results_summary": "PTENPs demonstrated strong anti-oxidant and anti-inflammatory effects in vitro and in vivo, effectively ameliorating acute IBD by inhibiting TLR4 activation and suppressing NF-\u03baB and MAPK signaling pathways, with low toxicity.", "population_specificity": "Colitis mice model.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:48.089810+00:00"}
{"study_id": 33540, "supplement_id": 1484, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether pterostilbene (Pte) and its metabolite pinostilbene (Pin) could enhance immune responses and suppress EV-D68 replication in human respiratory cells.", "results_summary": "Pte and Pin alleviated EV-D68-induced cytopathic effects, disrupted viral RNA replication (EC50 1.336\u20134.997 \u00b5M), and reduced infectious virion production without cytotoxicity. They also broadly suppressed replication in circulating EV-D68 strains.", "population_specificity": "Human respiratory cells infected with EV-D68.", "effective_dosage": "EC50 values ranged from 1.336 to 4.997 \u00b5M (specific dosing frequency not mentioned).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:50.137857+00:00"}
{"study_id": 33549, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the chemo-preventive effects of oral pterostilbene during different stages of skin squamous cell carcinoma (SCC) development in mouse models.", "results_summary": "Oral pterostilbene significantly reduced tumor number and volume, improved skin histology, and decreased cell proliferation markers compared to the cancer control group. It also showed fewer invasive tumors and less severe cellular changes.", "population_specificity": "Female Institute of Cancer Research (ICR) mice.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:54.851091+00:00"}
{"study_id": 33553, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the potential of Pterostilbene in reducing arthritis and peripheral neuropathy in CFA-induced arthritic rats.", "results_summary": "Pterostilbene significantly reduced inflammation, oxidative stress, and pain while improving motor activity and neurotransmitter levels in arthritic rats. It also mitigated cartilage damage and synovial hyperplasia.", "population_specificity": "CFA-induced arthritic rats", "effective_dosage": "12.5, 25, and 50 mg/kg orally", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:54.879338+00:00"}
{"study_id": 33550, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether pterostilbene could mitigate endoplasmic reticulum (ER) stress and restore autophagic flux to improve colon inflammation and barrier dysfunction in IUGR piglets and TNF-\u03b1-treated Caco-2 cells.", "results_summary": "Pterostilbene inhibited ER stress, restored autophagic flux, reduced inflammatory cytokines and apoptosis, improved intestinal barrier function, and its positive effects were blocked by ER stress and autophagy inhibitors.", "population_specificity": "IUGR piglets and TNF-\u03b1-treated human colonic epithelial cells (Caco-2).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:55.144970+00:00"}
{"study_id": 33551, "supplement_id": 1484, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to summarize the therapeutic potential of Pterostilbene (PTS) across various diseases, focusing on its mechanisms, pharmacokinetics, and strategies to enhance bioavailability.", "results_summary": "PTS exhibits robust pharmacodynamic features, including better absorption and hepatic stability than resveratrol, with potential benefits for diabetes, cancer, cardiovascular disease, neurodegenerative disorders, and aging. The review highlights Nrf2-mediated effects in diabetes and discusses formulations to improve bio-accessibility.", "population_specificity": "Not specified (broad review of experimental and clinical studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:55.349357+00:00"}
{"study_id": 33555, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of dietary pterostilbene supplementation on physicochemical changes and gel properties of myofibrillar protein in chicken during short-term frozen storage.", "results_summary": "Pterostilbene reduced protein oxidation, maintained structural stability, and improved gel quality (strength, whiteness, water-holding capacity) in chicken myofibrillar protein. It also promoted a dense, homogeneous gel network structure.", "population_specificity": "Postmortem chicken breast muscle (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Short-term frozen storage (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:56.524056+00:00"}
{"study_id": 33552, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the anti-osteoporotic potential of PTER-ITC in a glucocorticoid-induced osteoporosis (GIOP) rat model and its bone formation potential in vitro, including identifying its molecular target.", "results_summary": "PTER-ITC demonstrated osteogenic differentiation potential in pre-osteoblastic cells and inhibited osteoclastogenesis by targeting the RANK/TRAF6 interaction. It also improved bone architecture, physiology, and histology in GIOP rats, supported by serum biomarker analysis.", "population_specificity": "Female Wistar rats (in vivo) and pre-osteoblastic mouse MC3T3-E1, human hFOB 1.19, mouse RAW 264.7, and human THP-1 macrophagic cells (in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:58.066366+00:00"}
{"study_id": 33554, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a folate-modified pterostilbene-loaded polymeric micellar delivery system (F-Pt/M) to enhance blood-brain barrier penetration and brain tissue targeting for treating brain diseases.", "results_summary": "The study found that F-Pt/M significantly improved drug solubility, cytotoxicity against FR-overexpressing cells, and BBB penetration compared to free Pt. The system demonstrated sustained release behavior and enhanced brain targeting with a drug targeting index of 4.89.", "population_specificity": "In vitro studies using FR-overexpressing A172 cells and BBB models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:58.350194+00:00"}
{"study_id": 33556, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the therapeutic effects of Pterostilbene (PTE) on articular chondrocyte senescence and osteoarthritis (OA) and its underlying mechanisms.", "results_summary": "PTE significantly reduced OA-related damage and inflammation in rats, decreased markers of cellular senescence, and inhibited key signaling pathways (PI3K/AKT/NF-\u03baB) associated with OA progression.", "population_specificity": "Male Sprague-Dawley rats with induced OA.", "effective_dosage": "20 mg/kg, intraperitoneal injection.", "study_duration": "5 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:59.484728+00:00"}
{"study_id": 33560, "supplement_id": 1484, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "To formulate and evaluate the oral anti-obesity effects of polymeric-based pterostilbene-loaded nanoparticles.", "results_summary": "PS/HP\u03b2CD-NPs showed improved bioavailability and anti-obesity effects, supported by histological examination, lipid profile, and gene/protein expression of obesity biomarkers. The nanoparticles demonstrated sustainable weight loss with minimal side effects.", "population_specificity": "High-fat-diet-induced obesity rat model and Caco-2 cell line.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:02.940979+00:00"}
{"study_id": 33557, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antioxidant properties of pterostilbene (PS) combined with carboxyl-chitosan modified graphene (CG) for treating dry eye disease caused by oxidative stress.", "results_summary": "PS-CG demonstrated superior cellular permeability, sustained release, and antioxidant effects, reducing ROS levels, LDH content, and apoptosis in human corneal epithelial cells. In vivo tests showed increased tear production and healthier corneal and conjunctival epithelial cells in a dry eye mouse model.", "population_specificity": "Human corneal epithelial cells (HCEC) and a dry eye mouse model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:03.340377+00:00"}
{"study_id": 33561, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the oral bioavailability, organ/tissue distribution, and efficacy of a novel PTE pro-phytomicelle formulation against acetaminophen-induced liver damage in preclinical models.", "results_summary": "The PTE pro-phytomicelles significantly improved oral bioavailability and tissue distribution compared to bare PTE, and effectively reduced liver damage markers (ALT, AST), restored histopathology, and mitigated oxidative stress and inflammation via HMGB1 signaling regulation.", "population_specificity": "Rats and mice (preclinical animal models).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:03.842841+00:00"}
{"study_id": 33559, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether pterostilbene-loaded PLGA nanoparticles could effectively inhibit Aspergillus brasiliensis biofilm formation and infection in vitro and in vivo.", "results_summary": "PLGA-PTB-NPs reduced A. brasiliensis biofilm formation and mature biofilm, and in vivo experiments showed significantly lower mortality in infected larvae treated with PLGA-PTB-NPs compared to free PTB. The study demonstrated efficient nanoparticle uptake and enhanced PTB bioavailability in fungal biofilms.", "population_specificity": "Aspergillus brasiliensis (fungal biofilm model) and Galleria mellonella larvae (in vivo infection model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:03.943893+00:00"}
{"study_id": 33562, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Pterostilbene's ability to prevent intestinal epithelial barrier loss induced by high-intensity exercise in mice.", "results_summary": "Pterostilbene (100 mg/kg/d) significantly attenuated exercise-induced intestinal epithelial barrier loss, maintained high intestinal concentrations for 12 hours, and promoted tight junction molecule expression in vitro, though it did not reverse exercise-induced increases in Alistipes abundance.", "population_specificity": "Mice subjected to forced running as an exercise model.", "effective_dosage": "100 mg/kg per day", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:04.585413+00:00"}
{"study_id": 33563, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether pterostilbene could reduce ectopic lipid deposition and renal fibrosis in high-fat diet-induced diabetic mice.", "results_summary": "Pterostilbene reduced ectopic lipid deposition, improved kidney function, and alleviated renal fibrosis by inhibiting the TGF-\u03b21/smad3 signaling pathway. It also lowered protein levels of SREBP-1 and FAS, markers linked to lipid metabolism.", "population_specificity": "High-fat diet-induced diabetic mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:05.702137+00:00"}
{"study_id": 33564, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the laxative effect of Pterostilbene (PTE) on loperamide-induced slow transit constipation (STC) in mice and its influence on intestinal microbes.", "results_summary": "PTE significantly improved intestinal motility, reduced apoptosis of Cajal interstitial cells, enhanced PI3K/AKT and Nrf2/HO-1 signaling pathways, lowered oxidative stress, and restored gut microbial diversity in STC mice.", "population_specificity": "Loperamide-induced slow transit constipation (STC) mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:06.449506+00:00"}
{"study_id": 33565, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of pterostilbene on vascular dementia (VaD) and explore its underlying mechanisms using in vivo and in vitro models.", "results_summary": "Pterostilbene attenuated cognitive impairment in mice with bilateral common carotid artery occlusion (BCCAO), reduced hippocampal neuronal death and microglial activation, and inhibited TLR4 and downstream inflammatory cytokines. The anti-inflammatory effect was linked to Triad3A-mediated TLR4 degradation.", "population_specificity": "Mice with BCCAO and oxygen-glucose deprivation and reperfusion (OGD/R)-stimulated BV-2 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:09.365307+00:00"}
{"study_id": 33567, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of pterostilbene (Pt) and its derivative 3'-hydroxypterostilbene (OHPt) on lipid accumulation in HepG2 cells and NAFLD in C57BL/6J mice, focusing on SIRT1/AMPK and insulin signaling pathways.", "results_summary": "Pt and OHPt significantly reduced lipid accumulation in HepG2 cells and hepatic lipid droplets in mice, upregulated SIRT1/AMPK, and improved insulin resistance. OHPt was more effective than Pt, and both compounds positively altered gut microbiota.", "population_specificity": "HepG2 cells and C57BL/6J mice fed a high-fat diet.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:12.649846+00:00"}
{"study_id": 33569, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pterostilbene (PTS) could protect myocardial function in septic mice by reducing inflammation and oxidative stress.", "results_summary": "PTS significantly improved cardiac function in septic mice, reduced inflammatory markers (IL-1\u03b1, IL-6, MCP-1, IL-1\u03b2, NLRP3), inhibited fibrosis (collagen I, collagen III, \u03b1-SMA), and decreased oxidative stress (NOX1, NOX2, NOX4, DHE levels).", "population_specificity": "Mice with sepsis induced by lipopolysaccharide (LPS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:13.282089+00:00"}
{"study_id": 33570, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate pterostilbene's potential as a mitochondrial booster and its effects in combination with a mitochondrial cocktail (CoC3) on improving pathological alterations in mutant fibroblasts and induced neurons.", "results_summary": "Pterostilbene, particularly in combination with CoC3, enhanced sirtuins' activity and UPRmt activation, leading to improved pathological alterations in mutant fibroblasts and induced neurons. The positive effects were significantly increased when used in combination with CoC3.", "population_specificity": "Mutant fibroblasts and induced neurons (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:13.309169+00:00"}
{"study_id": 33566, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pterostilbene (PTS) could protect against doxorubicin (DOX)-induced hepatotoxicity in mice and HepG2 cells by examining its effects on oxidative stress, fibrosis, NLRP3 inflammasome stimulation, and apoptosis.", "results_summary": "PTS ameliorated DOX-induced liver damage by reducing oxidative stress, fibrosis, NLRP3 inflammasome activation, and apoptosis, while increasing antioxidant levels (SOD, GSH, Trx-1) and anti-apoptotic markers (BCL-2). In vitro, PTS reduced ROS and NLRP3 inflammasome levels and protected HepG2 cells from DOX-induced apoptosis.", "population_specificity": "C57/BL6J mice and HepG2 cell line.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:13.546719+00:00"}
{"study_id": 33568, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining pterostilbene (PTE) with sunitinib (SUN) enhances antitumor activity in gastric cancer cell lines and identifies potential mechanisms.", "results_summary": "The study found that combining PTE with SUN significantly suppressed cell proliferation, increased oxidative stress, and retained mitochondrial Fe2+ in gastric cancer cells. In vivo, the combination showed pronounced antitumor effects compared to SUN alone, suggesting PDZD8 as a potential off-target for SUN.", "population_specificity": "Human gastric cancer cell lines (TMK1 and MKN74) and a nude mouse tumor model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:13.765983+00:00"}
{"study_id": 196278, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the potential of pterostilbene as an alternative medicine for cancer treatment, addressing drug resistance and metastatic recurrence.", "results_summary": "The abstract does not provide specific results regarding pterostilbene's effects, only mentioning cumulative evidence supporting its potential.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided in the abstract.", "study_duration": "Not provided in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:14.260615+00:00"}
{"study_id": 33571, "supplement_id": 1484, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of pterostilbene (PTE) on the proliferation, differentiation, inflammation, and apoptosis of human periodontal ligament stem cells (hPDLSCs) and its potential role in periodontitis treatment.", "results_summary": "PTE promoted hPDLSC proliferation, reduced inflammatory factors, alleviated apoptosis, and enhanced mineralization. It also inhibited HDAC expression, suggesting a potential mechanism for its effects in periodontitis.", "population_specificity": "Human periodontal ligament stem cells (hPDLSCs)", "effective_dosage": "1, 5, 10, and 20 \u00b5M concentrations", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:14.277712+00:00"}
{"study_id": 34129, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of 6% Pueraria mirifica vaginal gel versus placebo on vaginal blood flow, tissue health, and genitourinary symptoms in postmenopausal women.", "results_summary": "Pueraria mirifica gel significantly improved vaginal blood flow (reduced PI and RI), increased vaginal maturation index (VMI), and enhanced vaginal health index (VHI) compared to placebo after 12 weeks. All measured parameters showed statistically significant improvements in the treatment group.", "population_specificity": "Postmenopausal women with genitourinary syndrome of menopause (GSM).", "effective_dosage": "6% Pueraria mirifica vaginal gel (frequency not specified).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:18.977400+00:00"}
{"study_id": 34130, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To compare the effects of 5% Pueraria mirifica gel versus placebo on bacterial vaginosis, vaginal health, and genitourinary symptoms in postmenopausal women.", "results_summary": "Pueraria mirifica gel significantly reduced abnormal Nugent scores and improved vaginal health index compared to placebo, but did not significantly alleviate genitourinary symptoms.", "population_specificity": "Postmenopausal women", "effective_dosage": "5% Pueraria mirifica gel (frequency not specified)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:20.186293+00:00"}
{"study_id": 34131, "supplement_id": 1485, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of Pueraria mirifica gel and conjugated estrogen cream on vaginal health in postmenopausal women with vulvovaginal symptoms.", "results_summary": "Pueraria mirifica gel significantly improved vaginal maturation index and reduced vaginal symptoms, though conjugated estrogen cream showed greater efficacy in restoring vaginal epithelium. Both treatments were effective, with no significant difference in symptom relief between the two.", "population_specificity": "Postmenopausal women with at least one vulvovaginal symptom (dryness, soreness, irritation, dyspareunia, or discharge).", "effective_dosage": "0.5\u200ag intravaginally daily for 2 weeks, then three times per week for 10 weeks.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:23.041942+00:00"}
{"study_id": 34134, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of Pueraria Mirifica extract, daidzein, and genistein on testosterone-induced prostatic hyperplasia in rats.", "results_summary": "The study found that Pueraria Mirifica extract, daidzein, and genistein reduced prostate/body weight ratio and improved prostatic cell histoarchitecture in testosterone-induced rats, indicating protective activity against benign prostatic hyperplasia.", "population_specificity": "Testosterone-induced prostatic hyperplasia in rats.", "effective_dosage": "Not specified (only testosterone dosage mentioned: 3 mg kg(-1)).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:23.106533+00:00"}
{"study_id": 34136, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of miroestrol (MR) from Pueraria mirifica on antioxidant systems in the livers and uteri of normal and procarcinogen-exposed mice.", "results_summary": "MR improved antioxidant activities (SOD, CAT) in both normal and BNF-treated mice, increased glutathione levels in the liver, and reduced lipid peroxidation in the uterus. Estradiol (E2) showed similar but less consistent effects compared to MR.", "population_specificity": "\u03b2-naphthoflavone (BNF)-treated mice (a model of procarcinogen exposure) and normal mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:23.478408+00:00"}
{"study_id": 34132, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the anti-osteoporotic effects of Pueraria Mirifica in postmenopausal monkeys to assess its potential applicability for human use.", "results_summary": "Pueraria Mirifica treatment (1000 mg/kg BW) ameliorated cortical bone loss by reducing bone turnover, improving bone quantity (BMC and BMD) and quality (bone geometry), while untreated monkeys showed continuous cortical bone deterioration.", "population_specificity": "Postmenopausal osteoporotic monkeys (n=10, divided into two groups).", "effective_dosage": "1000 mg/kg body weight daily.", "study_duration": "16 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:23.529979+00:00"}
{"study_id": 34133, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the neurotherapeutic effects of Pueraria mirifica extract (PME) and pure puerarin (PU) with 17\u03b2-estradiol (E2) in early- and late-stage cognitive impaired rats.", "results_summary": "PME and PU showed neurotherapeutic effects via different pathways, with PME improving estrogen deficiency symptoms and both reducing amyloid-related gene expression. Earlier treatment was more effective, with E2 showing the strongest cognitive improvement.", "population_specificity": "Ovariectomized (OVX) rats with early- and late-stage cognitive impairment.", "effective_dosage": "100 mg/kg PME, 7 mg/kg PU, and 80 \u00b5g/kg E2 administered daily.", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:23.758024+00:00"}
{"study_id": 34135, "supplement_id": 1485, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the estrogenic efficacy and systemic side effects of topical vaginal Pueraria mirifica extract in restoring vaginal atrophy in postmenopausal cynomolgus macaques.", "results_summary": "Pueraria mirifica significantly increased superficial vaginal cells and reduced vaginal pH, showing similar efficacy to conjugated equine estrogen (CEE) at 1% concentration, without causing systemic side effects observed with CEE.", "population_specificity": "Postmenopausal cynomolgus macaques with at least 5 years of complete cessation of menstruation.", "effective_dosage": "0.1% or 1% (w/w) PM cream applied topically daily.", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:23.794354+00:00"}
{"study_id": 34137, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Pueraria Mirifica (PM) and its active phytoestrogen, miroestrol (MR), on oxidative status in ovariectomized (OVX) mice, comparing them to synthetic estradiol.", "results_summary": "PM and MR significantly increased glutathione (GSH) levels and the ratio of GSH to oxidized glutathione (GSSG) in the livers and uteri of OVX mice, while estradiol did not. They also restored the activities of antioxidative enzymes (GPx, SOD, CAT) to normal levels.", "population_specificity": "Ovariectomized (OVX) mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:28.317248+00:00"}
{"study_id": 34138, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Pueraria mirifica extract and its major isoflavone, puerarin, on osteoblast differentiation and proliferation in rat osteoblast-like cells to understand its potential role in preventing postmenopausal osteoporosis.", "results_summary": "Pueraria mirifica extract and puerarin significantly increased markers of osteoblast differentiation (ALP and osteoprotegerin) and decreased an osteoclastogenic factor, suggesting a dual mechanism for bone gain. These effects were ER-dependent, as they were abolished by an estrogen receptor antagonist.", "population_specificity": "Rat osteoblast-like UMR106 cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:29.474952+00:00"}
{"study_id": 34139, "supplement_id": 1485, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "To compare the effectiveness and safety of Pueraria mirifica at 25 mg and 50 mg dosages in relieving menopausal symptoms in hysterectomized women.", "results_summary": "Both dosages of Pueraria mirifica significantly reduced menopausal symptoms over 6 months, with no significant difference between the two doses. No significant side effects were observed.", "population_specificity": "52 hysterectomized women with menopausal symptoms requiring hormone therapy.", "effective_dosage": "25 mg and 50 mg tablets daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:31.399020+00:00"}
{"study_id": 34141, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the estrogen-like effects of Pueraria Mirifica on vaginal and urethral cytology, bladder function, and leak point pressure in ovariectomized rats.", "results_summary": "Pueraria Mirifica (100 and 1,000 mg/kg/day) increased vaginal and urethral superficial cells and leak point pressure, similar to estradiol, but did not affect bladder capacity or residual urine volume.", "population_specificity": "Ovariectomized female Sprague-Dawley rats", "effective_dosage": "100 mg/kg/day and 1,000 mg/kg/day", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:31.945847+00:00"}
{"study_id": 34142, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of Pueraria Mirifica on lipid metabolism in postmenopausal women and explore the underlying molecular mechanisms involving estrogen receptors.", "results_summary": "Pueraria Mirifica significantly increased HDL cholesterol and apo A-1 while decreasing LDL cholesterol, apo B, and their ratios, suggesting beneficial effects on lipid metabolism. Phytoestrogens in PM, particularly miroestrol and coumestrol, activated both ERalpha and ERbeta, while others like daidzein and genistein preferentially activated ERbeta.", "population_specificity": "Postmenopausal women", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:32.234352+00:00"}
{"study_id": 34144, "supplement_id": 1485, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Pueraria Mirifica could prevent bone loss in ovariectomized rats, modeling postmenopausal osteoporosis.", "results_summary": "Pueraria Mirifica dose-dependently prevented bone loss in ovariectomized rats, with complete prevention at higher doses (100 and 1000 mg/kg), comparable to estrogen treatment. Effects varied by bone type, site, and compartment.", "population_specificity": "Fully mature ovariectomized rats (modeling postmenopausal women).", "effective_dosage": "0, 10, 100, and 1000 mg/kg body weight/day.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:32.795073+00:00"}
{"study_id": 34143, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pueraria Mirifica affects synaptic density by inducing synaptophysin expression via estrogen receptors.", "results_summary": "Pueraria Mirifica and 17beta-estradiol significantly increased synaptophysin immunoreactivity and levels after 4 days of treatment, with a dose-related effect up to 60 \u00b5g/ml. The effect was blocked by an estrogen receptor antagonist, indicating estrogen receptor involvement.", "population_specificity": "Hippocampal primary cell cultures at 6 days in vitro.", "effective_dosage": "Up to 60 \u00b5g/ml.", "study_duration": "2 and 4 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:33.847275+00:00"}
{"study_id": 34140, "supplement_id": 1485, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the mutagenic and antimutagenic activity of Pueraria Mirifica and Pueraria Lobata extracts using the Ames test and other assays.", "results_summary": "The study found that Pueraria Mirifica exhibited no mutagenic activity and demonstrated antimutagenic effects against specific mutagens. The extracts were non-toxic and safe at tested doses.", "population_specificity": "Salmonella typhimurium strains TA98 and TA100 (in vitro), rats (in vivo).", "effective_dosage": "2.5, 5, 10, or 20 mg/plate (in vitro); up to 300 mg/kg body weight (in vivo).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:33.934011+00:00"}
{"study_id": 34145, "supplement_id": 1485, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "To evaluate the effects of Pueraria mirifica on lipid profiles, bone turnover rates, and safety in postmenopausal women, including its impact on endometrial, breast, hepatic, and renal systems.", "results_summary": "Pueraria mirifica showed an estrogen-like effect on bone turnover but not on endometrial thickness or histology. Both Pueraria mirifica and placebo increased triglyceride levels, with no significant adverse effects on breast tissue, blood counts, or liver and renal function.", "population_specificity": "Healthy postmenopausal women aged 45-60 years.", "effective_dosage": "20, 30, or 50 mg once daily.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:37.873366+00:00"}
{"study_id": 34146, "supplement_id": 1485, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of Pueraria Mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in alleviating climacteric symptoms in perimenopausal women.", "results_summary": "PM showed similar efficacy to CEE in reducing climacteric symptoms, with no statistically significant differences in symptom relief or serum hormone levels between the two groups. The study concluded that PM has estrogenic effects comparable to CEE and is effective for symptom alleviation.", "population_specificity": "Perimenopausal women with climacteric symptoms attending a menopausal clinic.", "effective_dosage": "50 mg daily (PM group); 0.625 mg CEE with/without 2.5 mg MPA daily (control group).", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:39.752745+00:00"}
{"study_id": 34147, "supplement_id": 1485, "safety_score": "70", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of long-term Pueraria Mirifica administration on ovarian function and fertility in adult female mice.", "results_summary": "PM at 10 mg/kg BW/day showed no adverse effects, while 100 mg/kg BW/day and synthetic estrogen (DES) disrupted estrous cycles, reduced mating efficiency, and altered ovarian histology, though pregnancy and offspring health were unaffected.", "population_specificity": "Adult female mice", "effective_dosage": "0, 10, or 100 mg/kg BW/day (oral); 200 \u00b5g/kg BW/day DES (subcutaneous)", "study_duration": "8 weeks treatment, 8 weeks post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:40.496165+00:00"}
{"study_id": 34148, "supplement_id": 1485, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "To evaluate the effects of Pueraria mirifica on vaginal symptoms, vaginal health index, pH, and cytology in healthy postmenopausal women.", "results_summary": "Pueraria mirifica reduced vaginal dryness, improved vaginal maturation index, and restored atrophic vaginal epithelium without significant adverse effects compared to placebo.", "population_specificity": "Healthy postmenopausal women aged 45-60 years.", "effective_dosage": "20, 30, or 50 mg once daily.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:40.497568+00:00"}
{"study_id": 34150, "supplement_id": 1485, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Pueraria Mirifica on urinary hormone levels (FSH, LH, estradiol, progesterone) in female monkeys after single-dose and long-term treatments.", "results_summary": "Single-dose and daily 10 mg PM treatments showed no changes in hormone levels. Daily 100 mg and 1,000 mg PM treatments for 90 days reduced urinary FSH levels, suggesting FSH as an indicator of estrogenic effects.", "population_specificity": "Female monkeys (Macaca fascicularis)", "effective_dosage": "10, 100, or 1,000 mg orally (single-dose and daily for 90 days)", "study_duration": "Single-dose and 90-day daily treatments", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:41.984841+00:00"}
{"study_id": 34152, "supplement_id": 1485, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Pueraria Mirifica could prevent bone loss in orchidectomized male rats without affecting reproductive organs.", "results_summary": "Pueraria Mirifica dose-dependently prevented bone loss in trabecular and cortical bones without altering the weights of accessory sex organs. The effects varied by bone type and site.", "population_specificity": "Orchidectomized male rats.", "effective_dosage": "0, 10, 100, and 1000 mg/kg body weight/day.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:42.334469+00:00"}
{"study_id": 34149, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to evaluate the estrogenic activity of Pueraria mirifica samples from different Thai provinces using a vaginal cornification assay in ovariectomized rats.", "results_summary": "Pueraria mirifica showed dose-dependent estrogenic activity, with 100 mg/kg BW inducing vaginal cornification in 13 out of 25 samples and 1,000 mg/kg BW producing consistent effects. The onset of cornification was faster with 1,000 mg/kg BW (4.08 days) compared to 2 mg/kg BW estradiol (2 days), but the overall duration of cornification was shorter.", "population_specificity": "Ovariectomized rats", "effective_dosage": "10, 100, and 1,000 mg/kg BW daily", "study_duration": "14 consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:42.453525+00:00"}
{"study_id": 34151, "supplement_id": 1485, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Pueraria Mirifica on reproductive organs and fertility in adult male mice, comparing it to synthetic estrogen.", "results_summary": "Pueraria Mirifica at 10 and 100 mg/kg BW/d showed no significant effects on testicular weight, sperm count, or hormone levels, though the higher dose reduced epididymal/seminal vesicle weight and sperm motility. No persistent effects or fertility impairments were observed, and mating efficiency improved post-treatment.", "population_specificity": "Adult male mice", "effective_dosage": "10 and 100 mg/kg BW/d, orally administered", "study_duration": "8 weeks treatment, 8 weeks post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:43.004324+00:00"}
{"study_id": 34153, "supplement_id": 1485, "safety_score": "80", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Pueraria Mirifica improves endothelial function and cardiovascular health in ovariectomized rabbits, focusing on nitric oxide-dependent pathways and vascular responses.", "results_summary": "PM improved endothelial function by enhancing nitric oxide production, increasing responsiveness to estrogen, and reducing sensitivity to norepinephrine, without affecting lipid profiles or liver enzymes.", "population_specificity": "Ovariectomized White New Zealand rabbits", "effective_dosage": "100 mg/kg daily", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:45.717730+00:00"}
{"study_id": 34154, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the estrogenic effect of Pueraria Mirifica by studying changes in sexual skin coloration in aged menopausal monkeys.", "results_summary": "Pueraria Mirifica induced reddish sexual skin coloration within 24 hours of treatment, which persisted for the first half of the feeding period. The effect was not dose-dependent, indicating estrogenic action.", "population_specificity": "Aged menopausal cynomolgus monkeys (n=9, divided into three groups).", "effective_dosage": "10, 100, or 1,000 mg daily.", "study_duration": "90-day treatment period (preceded by 30-day pre-treatment and followed by 60-day post-treatment).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:48.757697+00:00"}
{"study_id": 34156, "supplement_id": 1485, "safety_score": "30", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the mutagenic effects of Pueraria Mirifica and the potential antimutagenic activity of Thunbergia laurifolia against these effects.", "results_summary": "Pueraria Mirifica at doses of 600 and 800 mg/kg induced higher frequencies of micronuclei, indicating mutagenic activity. Thunbergia laurifolia extracts significantly inhibited this mutagenic effect when combined with Pueraria Mirifica.", "population_specificity": "Male rats", "effective_dosage": "400, 600, and 800 mg/kg (oral administration)", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:49.378378+00:00"}
{"study_id": 34155, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effect of Pueraria Mirifica on gonadotrophin and estradiol levels in aged menopausal monkeys.", "results_summary": "Pueraria Mirifica suppressed gonadotrophin levels (FSH and LH) in a dose-dependent manner, with higher doses showing more prolonged effects post-treatment. Estradiol levels tended to decrease during treatment, and effects were reversible after discontinuation.", "population_specificity": "Aged menopausal cynomolgus monkeys (n = 9).", "effective_dosage": "10, 100, and 1000 mg/day.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:49.397858+00:00"}
{"study_id": 34157, "supplement_id": 1485, "safety_score": "30", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of Pueraria Mirifica on menstrual cycle length and related reproductive hormones in adult female monkeys.", "results_summary": "Pueraria Mirifica significantly increased menstrual cycle length at lower doses (10 and 100 mg/d) and completely suppressed menstruation at the highest dose (1000 mg/d). Hormonal levels (FSH, LH, estradiol, progesterone, and inhibin) decreased dose-dependently during treatment, with recovery post-treatment only in the lower-dose groups.", "population_specificity": "Adult female monkeys (Macaca fascicularis)", "effective_dosage": "10, 100, and 1000 mg/d", "study_duration": "Three menstrual cycles", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:51.265462+00:00"}
{"study_id": 34158, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of Pueraria Mirifica on serum parathyroid hormone (PTH) and calcium levels in aged menopausal monkeys.", "results_summary": "PM-1,000 mg/day significantly decreased PTH and calcium levels during treatment, with effects persisting for 15 days post-treatment. PM-10 mg/day also showed significant but less consistent effects, while PM-100 mg/day had no impact. Estradiol levels decreased in all treatment groups.", "population_specificity": "Aged menopausal monkeys (Macaca fascicularis)", "effective_dosage": "10, 100, or 1,000 mg/day", "study_duration": "90 days (treatment period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:51.287471+00:00"}
{"study_id": 34161, "supplement_id": 1485, "safety_score": "75", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the preliminary efficacy and safety of Pueraria mirifica in alleviating vasomotor symptoms (e.g., hot flushes, night sweats) in pre- and postmenopausal women.", "results_summary": "Pueraria mirifica reduced climacteric symptoms, as measured by the modified Greene climacteric scale, with both 50 mg and 100 mg doses showing improvement over six months. Some transient adverse effects (e.g., anemia, liver profile changes) were noted, but hormonal and lipoprotein changes were minor.", "population_specificity": "Pre- and postmenopausal women with vasomotor symptoms.", "effective_dosage": "50 mg/day or 100 mg/day, once daily.", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:52.738957+00:00"}
{"study_id": 34159, "supplement_id": 1485, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Pueraria mirifica, containing phytoestrogens, on the reproductive systems of gonadectomized male and female rats.", "results_summary": "Pueraria mirifica attenuated LH levels in both sexes and FSH levels in females at the highest dose (1,000 mg/kg), with effects recovering post-treatment. It increased uterine weight and vaginal cornification in females and epididymis weight in males, indicating greater reproductive system influence in females.", "population_specificity": "Gonadectomized male and female rats.", "effective_dosage": "0, 10, 100, and 1,000 mg/kg BW per day.", "study_duration": "14 days per period (pre-treatment, treatment, post-treatment).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:53.425076+00:00"}
{"study_id": 34163, "supplement_id": 1485, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the estrogenic effect of Pueraria Mirifica (PM) using recombinant yeast, MCF-7 cell proliferation, and HepG2 cell transient transfection assays.", "results_summary": "PM showed no estrogenic activity in the yeast system but induced estrogenic effects in MCF-7 and HepG2 cells in a dose-dependent manner, which was blocked by tamoxifen. The results suggest PM may require metabolic activation for estrogenic activity.", "population_specificity": "In vitro cell lines (MCF-7 and HepG2 cells) and recombinant yeast.", "effective_dosage": "0.025 ng/ml to 25 \u00b5g/ml concentrations.", "study_duration": "Not specified.", "interactions": "Tamoxifen blocked PM's estrogenic effect.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:59.599350+00:00"}
{"study_id": 34306, "supplement_id": 1486, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of red pumpkin seed (RPS) extract on melanosome transfer to keratinocytes and its role in mitigating UVB-induced oxidative stress.", "results_summary": "The RPS extract suppressed melanosome transfer stimulated by UVB or H2O2 by activating the Nrf2 antioxidant pathway, reducing intracellular ROS levels, and downregulating POMC mRNA expression.", "population_specificity": "Keratinocytes in vitro (cell culture study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:08:59.633814+00:00"}
{"study_id": 34307, "supplement_id": 1486, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the bioactivity of pumpkin seed extract, particularly its effects on steroid-hormone receptors and its potential to inhibit the growth of cancer and hyperplastic cells.", "results_summary": "The study found no transactivational activity for androgen, estrogen, or progesterone receptors but observed significant cell growth inhibition (~40-50%) in prostate, breast, and colon cancer cells, as well as benign hyperplastic cells, with minimal effect on non-hyperplastic fibroblasts (~20%).", "population_specificity": "In vitro human cell lines (prostate cancer, breast cancer, colorectal adenocarcinoma, benign prostate hyperplasia, and dermal fibroblasts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:00.921349+00:00"}
{"study_id": 34308, "supplement_id": 1486, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if pumpkin seed extract could protect against cyclophosphamide-induced reproductive toxicity in rats by examining sperm characteristics, biochemical parameters, and epididymal histology.", "results_summary": "Pumpkin seed extract significantly improved sperm characteristics, increased total antioxidant capacity, and reduced histopathological damage in CP-treated rats, suggesting protective effects against reproductive toxicity.", "population_specificity": "Male adult Wistar rats", "effective_dosage": "300 mg/kg and 600 mg/kg", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:01.692209+00:00"}
{"study_id": 34313, "supplement_id": 1487, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy of Punarnava Mandura and Dhatri Lauha in treating Garbhini Pandu (anemia during pregnancy).", "results_summary": "Punarnava Mandura showed better clinical improvement and a statistically significant increase in hemoglobin levels compared to Dhatri Lauha, with no adverse drug reactions reported.", "population_specificity": "24 pregnant women with symptoms of Garbhini Pandu.", "effective_dosage": "Two 500 mg tablets of Punarnava Mandura thrice daily with 100 ml buttermilk.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:02.573141+00:00"}
{"study_id": 34305, "supplement_id": 1486, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate pumpkin seed extract as a prophylactic and treatment for DMH-induced colon cancer in Wistar rats.", "results_summary": "Pumpkin seed extract significantly reduced aberrant crypt foci (ACF), improved antioxidant levels (GSH and SOD), decreased nitrite content, and reduced hyperplasia in treated groups compared to controls. Pretreatment at 200 mg/kg showed notable benefits in colon health metrics.", "population_specificity": "Male Wistar rats", "effective_dosage": "100 mg/kg and 200 mg/kg", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:08.294316+00:00"}
{"study_id": 34314, "supplement_id": 1487, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the Panduhara and Rasayana effects of Punarnava Mandura in managing geriatric anemia (Pandu Roga).", "results_summary": "Punarnava Mandura showed significant improvement in anemia symptoms, quality of life, and clinical features like Dehabala, Agni Bala, and Sattwa Bala, with moderate to mild improvement observed in 30% and 70% of patients, respectively.", "population_specificity": "50 clinically diagnosed geriatric anemia patients (40 completed treatment).", "effective_dosage": "2 tablets (250 mg each) twice daily after meals with buttermilk.", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:08.297177+00:00"}
{"study_id": 34315, "supplement_id": 1487, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antiproliferative and immunomodulatory properties of Punarnava (Boerhaavia diffusa) root extract, specifically its effects on HeLa cell growth and cell cycle.", "results_summary": "The methanol:chloroform fraction (BDF 5) of Punarnava root extract significantly reduced HeLa cell proliferation after 48 hours at 200 \u03bcg/mL, inducing apoptosis via DNA fragmentation and caspase-9 activation. The antiproliferative effect was linked to inhibition of DNA synthesis in the S-phase of the cell cycle.", "population_specificity": "HeLa cells (in vitro study)", "effective_dosage": "200 \u03bcg/mL", "study_duration": "48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:08.381561+00:00"}
{"study_id": 34317, "supplement_id": 1489, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of repeated fumigation and a sorghum sudangrass cover crop on controlling purple nutsedge populations in tomato production.", "results_summary": "DMDS + metam potassium was the most effective fumigant for purple nutsedge control, while the sorghum cover crop unexpectedly increased purple nutsedge density compared to chemical fallow.", "population_specificity": "Tomato production fields in Florida infested with purple nutsedge.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:08.442605+00:00"}
{"study_id": 34304, "supplement_id": 1486, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of an oil-free hydroethanolic pumpkin seed extract on symptoms of benign prostatic hyperplasia (BPH) in men.", "results_summary": "The study found a significant 30.1% reduction in total IPSS, improved quality of life, decreased nocturia, and reduced postvoid residual urine volume after 12 weeks of supplementation. The extract was well-tolerated and effective in alleviating BPH-related symptoms.", "population_specificity": "60 men (average age 62.3 years) with symptomatic BPH.", "effective_dosage": "Once daily before bedtime (exact dosage not specified).", "study_duration": "3 months (12 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:09.170189+00:00"}
{"study_id": 34319, "supplement_id": 1489, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare cold tolerance among different nutsedge species, including Purple Nutsedge, by analyzing lipid composition and metabolic changes during cold exposure.", "results_summary": "Purple Nutsedge showed the lowest cold tolerance among the studied species, with minimal lipid content (<1% of dry weight) and no significant changes in starch, sugar, or protein content during cold exposure. Its lipid ratios and metabolic responses were less adaptive to cold compared to yellow nutsedge ecotypes.", "population_specificity": "Tubers of Purple Nutsedge (Cyperus rotundus L.) and yellow nutsedge ecotypes (Cyperus esculentus L.).", "effective_dosage": "Not specified", "study_duration": "6 weeks at 2\u00b0C", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:11.792834+00:00"}
{"study_id": 34318, "supplement_id": 1489, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of elevated CO2 levels on the efficacy of glyphosate and halosulfuron for controlling purple and yellow nutsedge.", "results_summary": "Elevated CO2 increased the growth of purple nutsedge (shoot and root dry weights) and yellow nutsedge (shoot, root, and tuber dry weights and counts). Both herbicides effectively controlled both species at all tested rates, regardless of CO2 concentration.", "population_specificity": "Purple and yellow nutsedge grown in 3.0-L containers under ambient or elevated CO2 conditions.", "effective_dosage": "0.5\u00d7, 1.0\u00d7, or 1.5\u00d7 of the manufacturer's labeled rate of halosulfuron, glyphosate, or a tank mix of both.", "study_duration": "3 weeks following herbicide application.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:11.861860+00:00"}
{"study_id": 34162, "supplement_id": 1485, "safety_score": "70", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to investigate the estrogenic effect of Pueraria mirifica on menstrual cycle length and ovarian hormone-related function in monkeys.", "results_summary": "A single dose of 1,000 mg of P. mirifica significantly increased follicular phase and total menstrual cycle length in monkeys, but no hormonal changes were observed. Lower doses (10 and 100 mg) showed no effect on cycle length or hormone levels.", "population_specificity": "Nine normal cyclic monkeys (Macaca fascicularis).", "effective_dosage": "Single doses of 10, 100, and 1,000 mg.", "study_duration": "One and two menstrual cycles post-treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:15.851435+00:00"}
{"study_id": 34309, "supplement_id": 1490, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether purslane extract could reduce intestinal inflammation associated with obesity by modulating the TLR4/NF-\u03baB signaling pathway.", "results_summary": "Purslane extract reduced bowel inflammation and colon shortening in obese mice by suppressing the TLR4/NF-\u03baB pathway, leading to decreased levels of pro-inflammatory cytokines TNF-\u03b1 and IL-6.", "population_specificity": "Male C57BL/6J mice fed a high-fat diet to induce obesity.", "effective_dosage": "200 mg/kg/day", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:16.046179+00:00"}
{"study_id": 34310, "supplement_id": 1490, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effect of purslane extract on endothelial function and the underlying mechanisms in diabetic-associated endothelial dysfunction.", "results_summary": "Purslane extract ameliorated impairments in endothelial function, reduced ER stress and oxidative stress, and activated AMPK/eNOS signaling in both cell cultures and diabetic obese mice. The effects were abolished by an AMPK inhibitor, indicating the mechanism of action.", "population_specificity": "Male C57BL/6 mice and primary rat aortic endothelial cells.", "effective_dosage": "200 mg/kg/day via intragastric gavage.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:16.758935+00:00"}
{"study_id": 34312, "supplement_id": 1490, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Purslane Extract (PE) in improving glucose control, blood pressure, and lipid profile in adults with type 2 diabetes mellitus (T2DM) already on a single oral hypoglycemic agent.", "results_summary": "PE significantly reduced systolic blood pressure in the total cohort and HbA1c in the subgroup of responders, with few mild adverse events reported. The effects were statistically significant but modest in clinical magnitude.", "population_specificity": "Adults with T2DM (mean age 52.4\u201358.3 years) treated with a single oral hypoglycemic agent at baseline.", "effective_dosage": "Three capsules of PE per day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:17.199465+00:00"}
{"study_id": 33672, "supplement_id": 1491, "safety_score": "95", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and preventive effects of Pycnogenol\u00ae on residual symptoms and recurrence in patients with vasculitis-related conditions during remission.", "results_summary": "Pycnogenol\u00ae significantly reduced symptom scores, ESR values, IL-6 levels, and oxidative stress while decreasing the need for NSAIDs or corticosteroids compared to controls. No side effects were reported.", "population_specificity": "124 otherwise healthy subjects with systemic lupus erythematosus, Beh\u00e7et's disease, Sj\u00f6gren Syndrome, or polyarteritis nodosa in remission.", "effective_dosage": "150 mg per day", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:17.606185+00:00"}
{"study_id": 34311, "supplement_id": 1490, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of ultrasonic coupling with purslane extract in inhibiting enzymatic browning in fresh-cut potatoes during storage.", "results_summary": "The study found that combining ultrasonic treatment with a low concentration of purslane extract (0.02%) was more effective at preventing browning than using purslane extract alone (0.05%). The combination significantly reduced enzyme activity (PPO and POD), preserved cell membrane integrity, and enhanced antioxidant capacity during storage.", "population_specificity": "Fresh-cut potato samples stored at 4\u00b0C.", "effective_dosage": "0.02% (w/w) purslane extract combined with 10-minute ultrasonic treatment.", "study_duration": "8 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:18.623042+00:00"}
{"study_id": 33673, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Pycnogenol\u00ae could protect against noise-induced hearing loss in a rat model.", "results_summary": "The study found that Pycnogenol\u00ae significantly improved auditory brainstem response thresholds and preserved cochlear morphology in rats exposed to noise, suggesting potential protective effects against noise-induced hearing loss.", "population_specificity": "Male Wistar albino rats", "effective_dosage": "40 mg/kg/day via gavage", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:19.305645+00:00"}
{"study_id": 33674, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol (PYC) could alleviate pulmonary toxicity induced by titanium dioxide nanoparticles (TiO2NPs) and explore its anti-inflammatory and antioxidant mechanisms.", "results_summary": "PYC reduced TiO2NP-induced pulmonary inflammation, mucus production, oxidative stress markers, and restored glutathione levels in mice. It also demonstrated antioxidant and anti-inflammatory effects in human airway epithelial cells by modulating TXNIP, cleaved-Cas3, and inflammatory mediators.", "population_specificity": "Mice and human airway epithelial cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:20.257687+00:00"}
{"study_id": 33677, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Pycnogenol\u00ae improves patient-reported health status and mitigates symptoms in individuals with post-COVID-19 condition (PCC).", "results_summary": "The abstract does not report results, as the study appears to be ongoing or recently completed without published outcomes.", "population_specificity": "Individuals with post-COVID-19 condition (PCC), stratified by symptom duration (\u22646 months vs. >6 months) and presence of chronic diseases.", "effective_dosage": "200 mg Pycnogenol\u00ae daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:24.771918+00:00"}
{"study_id": 33676, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify the active components of Pycnogenol and elucidate their anti-inflammatory mechanisms using UPLC-MS/MS, network pharmacology, and cell experiments.", "results_summary": "The study identified 768 compounds in Pycnogenol, with 19 showing anti-inflammatory effects targeting 85 proteins, particularly IL6, TNF, and IL1B. Cell experiments confirmed Pycnogenol reduced IL6 and IL1\u03b2 expression in LPS-induced BV2 cells, suggesting anti-inflammatory effects via IL17 and TNF pathways.", "population_specificity": "LPS-induced BV2 cells (microglial cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:24.869092+00:00"}
{"study_id": 33675, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the pro-apoptotic and anti-migrative effects of pycnogenol in a breast cancer cell line (MCF-7).", "results_summary": "Pycnogenol significantly reduced cell viability, induced apoptosis (evidenced by chromatin condensation and nuclear fragmentation), and inhibited migration in MCF-7 cells by downregulating Bcl-2, VEGF/FGF, and p53 mRNA expression. The inhibitory concentration (IC-50) was observed at 80 \u03bcg/mL.", "population_specificity": "MCF-7 breast cancer cell line (in vitro study).", "effective_dosage": "20-120 \u00b5g/ml (single 24-hour exposure).", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:25.345360+00:00"}
{"study_id": 33679, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to enhance the efficiency of Molnupiravir for COVID-19 therapy by modifying it with Pycnogenol and cellulose nanoparticles decorated with zinc oxide.", "results_summary": "The modified drug showed improved release efficiency (65-78%) and higher biological activity, including antioxidant and anti-inflammatory effects, with the ZnO nanocomposite performing best. Viral inhibition was modest (18.02-37.6%).", "population_specificity": "Not specified (in vitro or cell line study).", "effective_dosage": "400-800 \u00b5g/ml (concentration used in viral inhibition assay).", "study_duration": "19 hours (release efficiency measurement).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:26.170528+00:00"}
{"study_id": 33678, "supplement_id": 1491, "safety_score": "30", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the wound healing efficacy of Pycnogenol\u2122, both alone and in combination with C. oestroides extract, using composite dressings in a mouse model.", "results_summary": "Pycnogenol\u2122, either alone or combined with C. oestroides, failed to close wounds by the 16th day, with poor histological scores (15). It also appeared to induce skin thickening and increased body temperature.", "population_specificity": "SKH-hr2 hairless mice with surgical wounds.", "effective_dosage": "5% Pycnogenol\u2122 dressing.", "study_duration": "16 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:26.484526+00:00"}
{"study_id": 33680, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of Pycnogenol combined with L-arginine (PAL) in improving sexual function in men with mild to moderate erectile dysfunction (ED).", "results_summary": "The meta-analysis found significant improvements in erectile function, intercourse satisfaction, orgasmic function, overall satisfaction, and sexual desire scores with PAL therapy compared to the control group, though no significant difference in testosterone levels was observed.", "population_specificity": "Men with mild to moderate erectile dysfunction.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:27.772192+00:00"}
{"study_id": 33681, "supplement_id": 1491, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to develop a novel hybrid nanocomposite (Cs@Pyc.SOF) combining Pycnogenol with sofosbuvir and chitosan nanoparticles to evaluate its potential as an anti-HCV therapy.", "results_summary": "The nanocomposite showed high drug loading efficiency (83%) and controlled release rates (up to 94% at 48 hours). Cytotoxicity tests indicated safety and high viability in mouse normal liver cells (BNL), suggesting potential as an HCV treatment, though clinical validation is needed.", "population_specificity": "Mouse normal liver cells (BNL) in vitro.", "effective_dosage": "Not specified.", "study_duration": "Release rates measured up to 48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:28.069981+00:00"}
{"study_id": 33682, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuroprotective effects and therapeutic mechanisms of Pycnogenol post-treatment in a gerbil model of ischemia and reperfusion (IR) injury.", "results_summary": "Pycnogenol (100 mg/kg) significantly improved memory deficits, reduced blood-brain barrier leakage, and inhibited pro-inflammatory cytokine IL-1\u03b2 expression, demonstrating neuroprotective effects against IR injury. Lower doses (25 and 50 mg/kg) did not show significant effects.", "population_specificity": "Gerbils subjected to ischemia and reperfusion injury in the forebrain.", "effective_dosage": "25, 50, and 100 mg/kg, administered intraperitoneally immediately, at 24 hours, and 48 hours post-IR.", "study_duration": "Treatment administered over 48 hours post-IR.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:29.974079+00:00"}
{"study_id": 33684, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-inflammatory effects of pycnogenol, indomethacin, and their combination (PI) in rats, as well as their impact on stomach tissue.", "results_summary": "Pycnogenol suppressed COX-2 expression and oxidative stress, reduced indomethacin-induced stomach ulcers, and enhanced anti-inflammatory activity when combined with indomethacin. It also inhibited malondialdehyde increase and preserved glutathione levels in stomach tissue.", "population_specificity": "Albino Wistar male rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Positive interaction with indomethacin (PI combination showed superior anti-inflammatory effects).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:33.636487+00:00"}
{"study_id": 33685, "supplement_id": 1491, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the preventive effect of Pycnogenol supplementation on cognitive and motor symptoms in patients with Parkinson's disease.", "results_summary": "Pycnogenol significantly improved Karnofsky performance index, reduced oxidative stress, decreased peripheral edema, and alleviated key Parkinson's symptoms (tremor, bradykinesia, cognitive alterations, rigidity, speech impairment) and facial expression asymmetry compared to controls.", "population_specificity": "Patients with moderate, well-controlled Parkinson's disease under stable treatment.", "effective_dosage": "150 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:33.816410+00:00"}
{"study_id": 33686, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol could protect against organ damage caused by methotrexate (MTX) treatment.", "results_summary": "Pycnogenol significantly reduced MTX-induced oxidative damage, toxicity, inflammatory response, and histological damage in the liver, kidney, and heart in a dose-dependent manner. Biochemical and histological analyses confirmed its protective effects.", "population_specificity": "Not specified (animal model implied by dosage units mg/kg).", "effective_dosage": "10, 20, and 30 mg/kg.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:34.205919+00:00"}
{"study_id": 33683, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Pycnogenol's protective effects against gamma radiation-induced lung damage in rats, focusing on histopathological changes, enzymatic alterations, and DNA damage.", "results_summary": "Pycnogenol (especially at 300 mg/kg) significantly increased CAT and SOD activities, reduced MDA levels, and decreased DNA damage and radiation-induced lung injury compared to the irradiated group without treatment.", "population_specificity": "Adult male rats exposed to whole-body gamma irradiation.", "effective_dosage": "37.5 mg/kg, 75 mg/kg, 150 mg/kg, and 300 mg/kg administered orally 24, 48, and 72 hours before irradiation.", "study_duration": "3 days (pre- and post-irradiation).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:34.220135+00:00"}
{"study_id": 33687, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effectiveness of topically applied Pycnogenol in healing alkaline corneal ulcers in diabetic and normal rats.", "results_summary": "Pycnogenol improved corneal epithelial wound healing in normal rats and significantly enhanced healing in diabetic rats compared to controls. It also reduced inflammatory cell infiltration in diabetic rats.", "population_specificity": "Wistar rats (normal and diabetic) with induced corneal alkali-burn injuries.", "effective_dosage": "PY eye drops applied three times daily (specific concentration not stated).", "study_duration": "6 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:34.544926+00:00"}
{"study_id": 33688, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to comprehensively review the evidence on Pycnogenol's physiological and pharmacological properties, focusing on its therapeutic potential for reducing inflammation and oxidative stress in chronic diseases.", "results_summary": "The study suggests Pycnogenol may reduce inflammation and oxidative stress by modulating insulin receptor signaling, inhibiting pro-inflammatory cytokines, and enhancing antioxidant pathways, though these effects are not yet fully proven.", "population_specificity": "Not specified (general chronic disease context).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:35.719112+00:00"}
{"study_id": 33690, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol could mitigate lung fibrosis and inflammation in mice exposed to PHMG.", "results_summary": "Pycnogenol improved body and lung weight, reduced inflammatory cytokines and fibrosis-related factors, and decreased histopathological signs of inflammation/fibrosis in a dose-dependent manner. The higher dose (1 mg/kg/day) showed more pronounced effects.", "population_specificity": "PHMG-treated mice (n = 6 per group)", "effective_dosage": "0.3 mg/kg/day and 1 mg/kg/day", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:37.888468+00:00"}
{"study_id": 33689, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine Pycnogenol's effects on motor function, depression, and the expression of NF-\u0199B and Nrf2 genes in a Parkinson's disease mouse model.", "results_summary": "Pycnogenol significantly improved motor function, reduced catalepsy and depression, and increased Nrf2 gene expression, but did not significantly affect NF-\u0199B gene expression. It demonstrated neuroprotective effects through antioxidative and genomic mechanisms.", "population_specificity": "Adult male NMRI mice (Parkinson's disease model)", "effective_dosage": "10, 20, and 30 mg/kg by gavage", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:38.918408+00:00"}
{"study_id": 33693, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if oral Pycnogenol\u00ae supplementation could improve skin health in Han Chinese individuals working outdoors in Beijing under high environmental stress.", "results_summary": "Pycnogenol\u00ae prevented declines in skin hydration, transepidermal water loss, and skin darkening during dry seasons, while also improving viscoelastic skin properties like elasticity and recovery. No such benefits were observed with placebo.", "population_specificity": "Han Chinese adults working outdoors in Beijing, China.", "effective_dosage": "2 \u00d7 50 mg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:42.072741+00:00"}
{"study_id": 33694, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if Pycnogenol could protect against oxidative alterations in testicular and brain tissues caused by heat stress in rats.", "results_summary": "Pycnogenol reversed heat-induced oxidative damage by upregulating antioxidant genes and reducing pro-apoptotic markers, while restoring reproductive hormone levels and spermatogenesis to normal.", "population_specificity": "Male Wistar rats (6 weeks old)", "effective_dosage": "50 mg/kg body weight/day, orally dissolved in saline", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:43.211617+00:00"}
{"study_id": 33695, "supplement_id": 1491, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy, safety, and tolerability of oral Pycnogenol (75 mg twice daily) versus placebo, combined with sunscreen and a topical triple combination, for treating facial melasma.", "results_summary": "Pycnogenol significantly improved melasma severity (mMASI scores), quality of life (MELASQoL), and colorimetric contrast compared to placebo, with no reported adverse effects. The treatment group showed a 49% reduction in mMASI scores versus 34% for placebo.", "population_specificity": "44 women with facial melasma, predominantly phototypes III-IV, mean age 39 years.", "effective_dosage": "75 mg orally twice daily", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:43.825263+00:00"}
{"study_id": 33692, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the suitability of a Pycnogenol-loaded bioadhesive film for treating open wounds, focusing on its mechanical properties, release kinetics, and effects on keratinocytes.", "results_summary": "The film demonstrated good absorbency (~65% wt/wt within 1 h), mechanical adaptability (elastic modulus E = 3.070 \u00b1 0.044 MPa), and sustained PYC release (~0.2 mg/mL over 24 h). PYC at 0.015 mg/mL stimulated keratinocyte growth without cytotoxicity.", "population_specificity": "Not specified (in vitro or ex vivo focus).", "effective_dosage": "Film released ~0.2 mg/mL PYC over 24 h, with 0.015 mg/mL achieved in the first 5 min.", "study_duration": "Not specified (release kinetics measured over 24 h).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:43.956429+00:00"}
{"study_id": 33696, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the neuroprotective effects and mechanisms of Pycnogenol\u00ae against ischemic injury following transient forebrain ischemia in gerbils.", "results_summary": "Pycnogenol\u00ae at 50 mg/kg protected learning, memory, and hippocampal pyramidal cells from ischemic injury, enhanced antioxidant enzyme activity, and reduced oxidative damage. Its neuroprotective effect was abolished by sodium azide, indicating an antioxidative mechanism.", "population_specificity": "Gerbils with induced transient forebrain ischemia.", "effective_dosage": "30, 40, and 50 mg/kg once daily.", "study_duration": "7 days before ischemia induction.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:45.147456+00:00"}
{"study_id": 33697, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to verify the neuroprotective effects of Pycnogenol (PYC) on spinal cord injury (SCI) and determine its underlying mechanisms.", "results_summary": "PYC improved motor function, reduced neuronal apoptosis, stabilized mitochondrial membrane potential, decreased oxidative stress markers (MDA), and increased antioxidant activity (SOD) in SCI rats. It also modulated apoptosis-related proteins (Cleaved-caspase 3, Bax, Bcl-2) and reduced Cyt-c release.", "population_specificity": "Male Wistar rats with induced spinal cord injury.", "effective_dosage": "100 mg/kg via intraperitoneal injection.", "study_duration": "Single dose administered 15 minutes post-SCI (duration of follow-up not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:47.258641+00:00"}
{"study_id": 33698, "supplement_id": 1491, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Pycnogenol (PYC) on cisplatin cytotoxicity in human cervix cancer cells (HeLa) and evaluate its genotoxicity.", "results_summary": "PYC increased cisplatin cytotoxicity at certain concentrations and reduced oxidative DNA damage at lower doses but induced DNA damage at higher doses. The results suggest PYC may enhance cisplatin's anticancer effect at non-genotoxic doses.", "population_specificity": "Human cervix cancer cells (HeLa) in vitro.", "effective_dosage": "10-500 \u03bcM (concentration-dependent effects).", "study_duration": "24 and 48 hours.", "interactions": "Interaction with cisplatin noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:47.617588+00:00"}
{"study_id": 33699, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine the safety and efficacy of a polyherbal medicine (including Pycnogenol) for reducing metabolic markers associated with pre-type 2 diabetes (pre-T2D).", "results_summary": "The study found no significant improvement in impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) in the intervention group compared to the control group. Blood cholesterol and triglyceride levels also remained unchanged.", "population_specificity": "Patients with pre-type 2 diabetes (pre-T2D).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:50.703788+00:00"}
{"study_id": 33701, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Pycnogenol supplementation improves clinical, nutritional, and inflammatory status in traumatic brain injury (TBI) patients.", "results_summary": "The study expects Pycnogenol to improve clinical and nutritional status while reducing inflammation and oxidative stress in TBI patients, though specific results are not yet provided in the abstract.", "population_specificity": "Traumatic brain injury (TBI) patients", "effective_dosage": "150 mg daily", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:51.268186+00:00"}
{"study_id": 33700, "supplement_id": 1491, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Pycnogenol\u00ae in treating primary, idiopathic mucosal dryness (xerostomia) in non-cancer subjects, comparing diabetics and non-diabetics.", "results_summary": "Pycnogenol\u00ae significantly improved salivary flow, reduced oxidative stress, decreased mucosal breaks and ulcerations, and increased lysozyme levels in both diabetic and non-diabetic subjects, with minimal improvements seen in the standard management group.", "population_specificity": "48 subjects (24 diabetics and 24 non-diabetics) with a BMI <26 kg/m\u00b2.", "effective_dosage": "150 mg/day", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:51.992940+00:00"}
{"study_id": 33702, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of Pycnogenol supplementation on accessory symptoms and cognitive functions in Parkinson's Disease patients under stable neurological treatment.", "results_summary": "Pycnogenol supplementation significantly attenuated target symptoms (tremor, bradykinesia, cognitive dysfunction, rigidity, speech changes) and reduced oxidative stress compared to standard management alone. Peripheral edema improved more in the supplemented group.", "population_specificity": "43 Parkinson's Disease patients with mild, minimally progressive symptoms on carbidopa/levodopa monotherapy.", "effective_dosage": "150 mg/day", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:52.345308+00:00"}
{"study_id": 33703, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to assess the impact of pycnogenol on blood pressure through a systematic review and meta-analysis of randomized, double-blind, placebo-controlled clinical studies.", "results_summary": "The meta-analysis of 7 trials involving 626 participants found no significant effect of pycnogenol on systolic blood pressure, diastolic blood pressure, mean arterial pressure, or pulse pressure. Results remained consistent in sensitivity analysis.", "population_specificity": "626 participants across 7 randomized clinical trials (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:53.271001+00:00"}
{"study_id": 33704, "supplement_id": 1491, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol\u00ae could reduce migraine headache attacks and oxidative stress in otherwise healthy subjects with moderate migraine headaches.", "results_summary": "Pycnogenol\u00ae significantly reduced the number of migraine attacks, pain scores, working incapacity, and use of rescue medications compared to standard management. It also lowered oxidative stress levels, unlike standard management or topiramate.", "population_specificity": "Otherwise healthy subjects with moderate migraine headaches.", "effective_dosage": "150 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:55.088694+00:00"}
{"study_id": 33705, "supplement_id": 1491, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of Pycnogenol\u00ae supplementation alongside standard management in reducing symptoms of mild, primary Raynaud syndrome compared to standard management alone.", "results_summary": "Pycnogenol\u00ae significantly reduced coldness, burning pain, paresthesias, and irregular color changes, improved finger temperature and skin flux, and decreased oxidative stress more than standard management alone. Fewer subjects in the Pycnogenol\u00ae group required additional drug treatment.", "population_specificity": "67 females aged 30-40 with mild, primary Raynaud syndrome, working in shops with refrigerators.", "effective_dosage": "100 mg/day", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:56.080256+00:00"}
{"study_id": 33706, "supplement_id": 1491, "safety_score": "95", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Pycnogenol's efficacy in controlling symptoms of chronic venous insufficiency (CVI) and improving microcirculatory parameters like venous hypertension and microangiopathy.", "results_summary": "Pycnogenol significantly improved microcirculation, reduced oxidative stress, and alleviated CVI symptoms, outperforming compression stockings alone. The combination of Pycnogenol and compression yielded the best results.", "population_specificity": "142 patients with chronic venous insufficiency during a summer period.", "effective_dosage": "150 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:58.777731+00:00"}
{"study_id": 33707, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate Pycnogenol's efficacy in reducing oxidative stress and side effects of levothyroxine (LT4) treatment in patients with primary hypothyroidism.", "results_summary": "Pycnogenol supplementation significantly reduced the global occurrence of symptoms compared to the control group (P<0.05), suggesting it may help mitigate LT4-related side effects.", "population_specificity": "60 females with primary hypothyroidism and multi-nodular goiter under initial LT4 treatment.", "effective_dosage": "150 mg Pycnogenol daily.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:59.731104+00:00"}
{"study_id": 33708, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Pycnogenol on ischemia/reperfusion (I/R) injury in rat brain tissues, focusing on oxidative and inflammatory damage.", "results_summary": "Pycnogenol reduced cortex damage, edema, and vasopathology in rats with I/R injury, lowered oxidative stress markers (MDA) and inflammatory markers (IL-1\u03b2, TNF-\u03b1), and improved antioxidant levels (GSH, GPO).", "population_specificity": "Albino Wistar rats", "effective_dosage": "Not specified", "study_duration": "24 hours of reperfusion following 30 minutes of transient ischemia", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:09:59.895177+00:00"}
{"study_id": 33709, "supplement_id": 1491, "safety_score": "95", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Pycnogenol's effectiveness in reducing recurrent retinal vein thrombosis (RVT) and its ability to control edema compared to other treatments.", "results_summary": "Pycnogenol significantly reduced recurrent RVT incidence (3.3% vs. 22.7% in controls) and better controlled edema (present in only 5.5% of subjects). It also demonstrated excellent tolerability and safety with no treatment discontinuations.", "population_specificity": "Subjects with a first episode of retinal vein thrombosis (RVT).", "effective_dosage": "100 mg/day", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:01.334754+00:00"}
{"study_id": 33710, "supplement_id": 1491, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Pycnogenol (PYC) could attenuate escitalopram-induced sexual dysfunction (SDys) in patients with depression.", "results_summary": "PYC co-treatment reduced SDys starting at 1 month and sustained the effect for two consecutive months, while also increasing heart rate. The study suggests PYC's benefits may stem from its antioxidant, anti-inflammatory, and vasodilatory properties.", "population_specificity": "72 outpatients (67 analyzed) of both genders with depression.", "effective_dosage": "50 mg of PYC per day.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:01.945887+00:00"}
{"study_id": 33711, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of Pycnogenol on DNA damage and biochemical changes in diabetic rats, focusing on oxidative stress, lipid profile, liver function, and DNA integrity.", "results_summary": "Pycnogenol treatment significantly improved oxidative stress markers, lipid profiles, liver function parameters, and reduced DNA damage in hyperglycemic rats, suggesting potential benefits for diabetes-related complications.", "population_specificity": "Experimental diabetic rats", "effective_dosage": "50 mg/kg/day, orally", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:03.062413+00:00"}
{"study_id": 33712, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Pycnogenol on PTZ-induced seizures in mice and assess its potential as an adjuvant therapy for epilepsy.", "results_summary": "Pycnogenol significantly increased seizure latency, reduced duration and frequency of convulsions, and improved biochemical markers (reduced TBARS, increased SOD, catalase, and GSH) without impairing cognitive functions or causing muscle relaxant effects. Histopathological findings showed less neuronal degeneration compared to controls.", "population_specificity": "Swiss strain mice weighing 18-30g.", "effective_dosage": "50 mg/kg and 100 mg/kg, administered orally.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:05.628248+00:00"}
{"study_id": 33713, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of Pycnogenol\u00ae supplementation on symptoms and inflammation in Sj\u00f6gren syndrome patients in remission.", "results_summary": "Pycnogenol\u00ae significantly reduced ESR and oxidative stress levels, improved symptoms like dry eyes and mouth dryness, and decreased the need for corticosteroids and other treatments.", "population_specificity": "Otherwise healthy subjects with Sj\u00f6gren syndrome in remission experiencing persistent symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:06.411206+00:00"}
{"study_id": 33714, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol could prevent testosterone propionate-induced benign prostate hyperplasia (BPH) in rats.", "results_summary": "Pycnogenol significantly reduced prostate weight, dihydrotestosterone (DHT) levels in serum and prostate, and expression of PCNA and Ki-67 proteins compared to BPH-induced rats, indicating inhibition of BPH development.", "population_specificity": "Male Sprague-Dawley rats", "effective_dosage": "20 or 40 mg/kg daily", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:08.263292+00:00"}
{"study_id": 33715, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of Pycnogenol supplementation on blood pressure through a meta-analysis of existing studies.", "results_summary": "Pycnogenol supplementation (150-200 mg/d) significantly reduced systolic and diastolic blood pressure, particularly in hypertensive participants or those treated for over 12 weeks, though this effect was not observed in well-designed trials.", "population_specificity": "549 participants across nine trials, including hypertensive individuals.", "effective_dosage": "150 mg/d to 200 mg/d", "study_duration": "Varied, with subgroup analysis for interventions longer than 12 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:09.149743+00:00"}
{"study_id": 33717, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effect of Pycnogenol on an experimental allergic conjunctivitis model in rats, comparing its efficacy and safety to dexamethasone.", "results_summary": "Pycnogenol (10 mg/kg) significantly reduced mast cell count and showed similar histological improvements to dexamethasone in alleviating allergic conjunctivitis symptoms, with no detrimental effects observed. Negative staining for TGF-\u03b2 and weak focal staining for TNF-\u03b1 were common in both treatment groups.", "population_specificity": "Rats with experimentally induced allergic conjunctivitis.", "effective_dosage": "3 or 10 mg/kg intraperitoneally.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:10.413237+00:00"}
{"study_id": 33718, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Pycnogenol on obesity and white adipose tissue browning in apolipoprotein E-deficient mice.", "results_summary": "Pycnogenol reversed body weight and fat mass gain induced by a high-cholesterol, high-fat diet, reduced adipocyte size, promoted lipolysis, and increased beige adipogenesis-related gene expression. It also activated the PKA signaling pathway.", "population_specificity": "Apolipoprotein E-deficient mice fed a high-cholesterol, high-fat diet.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:12.278739+00:00"}
{"study_id": 33716, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of Pycnogenol\u00ae supplementation over two months in healthy individuals with mild cognitive impairment, as measured by MMSE scores.", "results_summary": "Pycnogenol\u00ae supplementation significantly improved MMSE scores (18% median increase) compared to standard management (2.48% increase), with no significant adverse effects reported. The results suggest Pycnogenol\u00ae may benefit cognitive function in individuals with mild impairment.", "population_specificity": "Healthy subjects with mild cognitive impairment (MMSE score 18-23) and BMI <26 kg/m\u00b2, no metabolic disorders.", "effective_dosage": "150 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:12.645639+00:00"}
{"study_id": 33720, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the cellular mechanisms behind Pycnogenol's symptom-alleviating effects in patients with severe knee osteoarthritis.", "results_summary": "Pycnogenol significantly downregulated cartilage degradation markers (MMP3, MMP13, IL1B) in chondrocytes and reduced ADAMTS-5 protein levels in serum, suggesting anti-inflammatory and cartilage-protective effects.", "population_specificity": "Patients with severe knee osteoarthritis scheduled for knee arthroplasty.", "effective_dosage": "100 mg twice daily", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:14.471414+00:00"}
{"study_id": 33719, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the beneficial effects of Pycnogenol on diet-induced hepatic steatosis in ApoE-deficient mice.", "results_summary": "Pycnogenol reduced body weight, serum lipids, and hepatic lipid deposition while suppressing genes related to lipogenesis and inflammation, thereby protecting against hepatic steatosis.", "population_specificity": "Apolipoprotein E (ApoE)-deficient male mice fed a high-cholesterol and high-fat diet.", "effective_dosage": "30 or 100 mg\u00b7kg-1\u00b7day-1 orally.", "study_duration": "2 weeks pre-treatment followed by 8 weeks of high-cholesterol and high-fat diet.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:14.816437+00:00"}
{"study_id": 33721, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Pycnogenol on DNA damage and biochemical changes in blood, liver, and lung tissues of ischemia-reperfusion-induced rats.", "results_summary": "Pycnogenol significantly reduced oxidative stress markers (TOS, TTL, MPO, AOPP, ALT, AST, LDH) and DNA damage while increasing antioxidant status (TAS) compared to the IR group.", "population_specificity": "Wistar albino rats with induced ischemia-reperfusion injury.", "effective_dosage": "100 mg/kg administered via intraperitoneal injection.", "study_duration": "Single dose administered before IR inducement.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:17.497337+00:00"}
{"study_id": 33722, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol could mitigate pulmonary fibrosis and inflammation caused by cigarette smoke and LPS exposure in a mouse model of COPD.", "results_summary": "Pycnogenol reduced inflammatory cells and proinflammatory mediators, inhibited collagen deposition in lung tissue, and suppressed TGF-\u03b21/Smad 2/3 signaling, suggesting potential therapeutic benefits for COPD progression.", "population_specificity": "Mice exposed to cigarette smoke and LPS to model COPD.", "effective_dosage": "10 and 20 mg/kg administered orally once daily.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:17.951507+00:00"}
{"study_id": 33723, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the in vivo distribution of constituents or metabolites of Pycnogenol in patients with severe osteoarthritis.", "results_summary": "The study found significant interindividual variability in polyphenol pharmacokinetics, with the highest concentrations detected in blood cells and synovial fluid rather than serum. Taxifolin and ferulic acid were exclusively or predominantly present in the Pycnogenol-treated group, suggesting targeted distribution.", "population_specificity": "33 patients with severe osteoarthritis scheduled for knee arthroplasty.", "effective_dosage": "200 mg per day", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:19.134159+00:00"}
{"study_id": 33725, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of Pycnogenol\u00ae to methylphenidate and placebo on behavior, immunity, oxidative stress, and physical symptoms in pediatric ADHD and ADD patients.", "results_summary": "The abstract does not provide specific results for Pycnogenol\u00ae but indicates the study evaluated behavior, immune markers, oxidative stress, and physical complaints, with an active control arm for comparison.", "population_specificity": "Pediatric patients with ADHD and ADD (144 participants).", "effective_dosage": "Not specified in the abstract.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:20.849343+00:00"}
{"study_id": 33724, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Pycnogenol (PYC) on wound healing in healthy and diabetic rats compared to untreated and cleanser/silver sulfadiazine-treated wounds.", "results_summary": "PYC-treated wounds showed significantly greater wound size reduction (58.03%) compared to untreated (45.73%) and cleanser/SSD-treated (48.73%) wounds. PYC also improved collagen deposition and neovascularization in diabetic rats compared to cleanser/SSD treatment.", "population_specificity": "48 adult male Sprague-Dawley rats (24 healthy, 24 diabetic).", "effective_dosage": "30 mg PYC powder applied daily.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:21.256549+00:00"}
{"study_id": 33727, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Pycnogenol on allergic inflammation in a rat model of allergic rhinitis.", "results_summary": "Pycnogenol significantly reduced levels of inflammatory markers (IL-4, IFN-\u03b3, IL-10, TNF-\u03b1, IL-1\u03b2) and improved histopathological changes in nasal mucosa, demonstrating multiple suppressive effects on allergic response.", "population_specificity": "Rats with induced allergic rhinitis.", "effective_dosage": "3 mg/kg and 10 mg/kg.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:22.894755+00:00"}
{"study_id": 33726, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Pycnogenol in improving postpartum varicose veins (VVs) and venous function compared to elastic compression stockings.", "results_summary": "Pycnogenol significantly reduced the number of veins, incompetent sites, edema, spider veins, and minor symptoms compared to controls, with higher patient satisfaction and compliance. Most improvements occurred within 6 months, and results remained stable at 12 months.", "population_specificity": "Healthy women after their second pregnancy with postpartum varicose veins.", "effective_dosage": "100 mg/day", "study_duration": "At least 3 months of follow-up, with re-evaluation at 6 and 12 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:24.178041+00:00"}
{"study_id": 33729, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate Pycnogenol's potential to improve HCV-associated type 2 diabetes mellitus (T2DM) and its antiviral effects against HCV replication.", "results_summary": "The study suggests Pycnogenol may enhance conventional HCV therapy, mitigate HCV-associated T2DM, and reduce complications like cirrhosis, hepatocellular carcinoma, and cardiovascular disease. The review cites previously published data supporting its antidiabetic and antiviral properties.", "population_specificity": "Individuals with Hepatitis C virus (HCV) infection and type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:26.477895+00:00"}
{"study_id": 33728, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effectiveness and molecular mechanism of Pycnogenol (PYC) in regulating asthmatic airway inflammation, particularly its impact on the IL-13/JAK/STAT6 pathway and goblet cell metaplasia.", "results_summary": "PYC reduced ovalbumin-induced airway injury, inhibited inflammatory cells and cytokines (IL-4, IL-5, IL-9, IL-13), and suppressed the IL-13/JAK/STAT6 pathway, leading to decreased goblet cell metaplasia. PYC also showed high bioavailability (71.96%) and rapid absorption.", "population_specificity": "OVA-induced asthmatic mice", "effective_dosage": "50 mg/kg (tail intravenous injection) or 100 mg/kg (intragastric administration)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:27.753235+00:00"}
{"study_id": 33730, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol (PYC) improves cognitive function and reduces brain damage following traumatic brain injury (TBI) in rats.", "results_summary": "PYC at the highest dose (100mg/kg) significantly reduced lesion volume but did not improve cognitive function in the Morris water maze or reduce hippocampal neuron degeneration (FJB staining). The study suggests oxidative stress and neuroinflammation reduction may not be key to cognitive recovery post-TBI.", "population_specificity": "Adult Sprague-Dawley rats with controlled cortical impact (CCI) injury.", "effective_dosage": "50 or 100mg/kg intraperitoneal injection.", "study_duration": "Evaluated at 48h (FJB staining) and 7 days post-trauma (MWM and lesion volume).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:28.818733+00:00"}
{"study_id": 33691, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Pycnogenol's efficacy, antioxidant, and antiapoptotic effects in a hypoxic-ischemic rat model.", "results_summary": "Pycnogenol reduced neuronal cell injury and apoptosis in the cerebral tissue of rats with hypoxic-ischemic brain injury. The study suggests Pycnogenol may protect against hypoxic-ischemic encephalopathy.", "population_specificity": "Wistar albino rats on the seventh postnatal day with induced hypoxic-ischemic brain injury.", "effective_dosage": "40 mg/kg Pycnogenol.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:29.137657+00:00"}
{"study_id": 33731, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol could suppress atherosclerosis formation induced by a high cholesterol and fat diet in apolipoprotein E-deficient mice.", "results_summary": "Pycnogenol significantly reduced atherosclerotic lesion size, suppressed oxidized LDL-induced lipid accumulation in macrophages, and inhibited TLR4 expression and related inflammatory pathways (aP2 and SR-A) via the JNK pathway.", "population_specificity": "Apolipoprotein E-deficient mice fed a high cholesterol and fat diet.", "effective_dosage": "Not specified", "study_duration": "10 weeks (PYC administered for 10 weeks, with high cholesterol and fat diet during the latter 8 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:29.822425+00:00"}
{"study_id": 33732, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate Pycnogenol's ability to inhibit chronic obstructive pulmonary disease (COPD) in both human airway epithelial cells and a mouse model.", "results_summary": "Pycnogenol significantly reduced inflammatory markers and mucus production in human cells and decreased inflammatory cell counts and cytokine levels in the COPD mouse model, primarily via the Erk-sp1 pathway.", "population_specificity": "Human airway epithelial cell line NCI-H292 and a cigarette smoke/lipopolysaccharide-induced mouse model.", "effective_dosage": "15mg/kg and 30mg/kg administered 1h before cigarette smoke exposure in mice.", "study_duration": "7 days (mice exposed to cigarette smoke for 1h/day from days 1-7).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:30.807992+00:00"}
{"study_id": 33733, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of Pycnogenol and diosmin/hesperidin on venous ulcer healing in patients with chronic venous insufficiency.", "results_summary": "Pycnogenol showed a similar effect to diosmin/hesperidin in promoting venous ulcer healing and significantly reduced the circumference of affected limbs. Both treatments were effective, with statistically significant results (P < 0.0001).", "population_specificity": "30 adult patients with venous ulcers from a vascular surgery outpatient clinic.", "effective_dosage": "50 mg orally, 3 times daily.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:31.315850+00:00"}
{"study_id": 33734, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of Pycnogenol, alone or in combination with spirulina, against vancomycin-induced renal oxidative stress in rats.", "results_summary": "Pycnogenol reduced oxidative stress markers (e.g., malondialdehyde, Bax, LC3/B, inducible nitric oxide synthase) and improved antioxidant levels (e.g., glutathione, glutathione peroxidase, superoxide dismutase) and kidney function in vancomycin-treated rats. The combination of Pycnogenol and spirulina showed superior protective effects compared to monotherapy.", "population_specificity": "Rats (49 animals divided into 7 groups)", "effective_dosage": "200 mg/kg per day", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:34.043309+00:00"}
{"study_id": 33735, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of Pycnogenol as an add-on therapy to metformin in diabetic rats, focusing on cardiovascular and metabolic outcomes.", "results_summary": "Pycnogenol improved blood glucose levels, vascular reactivity, left ventricular hypertrophy, and expression of key proteins (AMPK, GLUT4, CaMKII) in the heart, but combining it with metformin did not enhance efficacy further.", "population_specificity": "Streptozotocin-induced diabetic rats.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:34.458182+00:00"}
{"study_id": 33736, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol could protect against cisplatin-induced ototoxicity in rats.", "results_summary": "Pycnogenol significantly reduced cisplatin-induced apoptosis in the organ of Corti and spiral ganglion neurons and improved auditory function, as measured by DPOAE, compared to cisplatin alone. The study concluded that Pycnogenol is protective against ototoxicity and is not ototoxic itself.", "population_specificity": "Rats (specifically, their auditory systems)", "effective_dosage": "10 mg/kg intraperitoneally for 7 days", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:36.437057+00:00"}
{"study_id": 33737, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate Pycnogenol's apoptotic effects and molecular mechanisms in human oral squamous cell carcinoma HSC-3 cells.", "results_summary": "Pycnogenol significantly inhibited HSC-3 cell viability, induced caspase-dependent apoptosis, increased Bak protein stability, and generated reactive oxygen species, suggesting potential for oral cancer chemoprevention or chemotherapy.", "population_specificity": "Human oral squamous cell carcinoma HSC-3 cells and TPA-treated JB6 cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:37.307677+00:00"}
{"study_id": 33738, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine Pycnogenol's protective effects against atherosclerosis and its underlying mechanisms, particularly its impact on lipid regulation and foam cell formation.", "results_summary": "Pycnogenol reduced plaque and lipid deposition in atherosclerotic mice, improved lipid profiles (lowered total cholesterol and triglycerides, increased HDL), and decreased foam cell formation in human THP-1 monocytes. It acted via the TLR4/NF-\u03baB pathway to suppress lipid-related proteins (ADRP, ALBP).", "population_specificity": "Atherosclerotic mice and LPS-stimulated human THP-1 monocytes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:38.758857+00:00"}
{"study_id": 33741, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol reduces proinflammatory mediator production in lipopolysaccharide-stimulated BV2 microglia and primary brain microglia.", "results_summary": "Pycnogenol treatment was associated with dose-dependent reductions in nitric oxide, TNF-\u03b1, IL-6, IL-1\u03b2, ICAM-1, and PLIN2 levels, as well as suppression of NF-\u03baB and AP-1 activation, without affecting anti-inflammatory IL-10 production.", "population_specificity": "Mouse-derived BV2 microglia and primary brain microglia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:39.768741+00:00"}
{"study_id": 33739, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Pycnogenol(\u00ae) combined with L-arginine in improving sperm quality and erectile function in infertile men with oligoasthenozoospermia and mild erectile dysfunction.", "results_summary": "The study found significant improvements in sperm concentration and erectile function scores (IIEF) after 4 months of treatment with Pycnogenol(\u00ae) and L-arginine. The combination therapy enhanced nitric oxide production and antioxidant effects, benefiting both sperm quality and erectile function.", "population_specificity": "Japanese men with oligoasthenoteratozoospermia syndrome (OAT) and mild erectile dysfunction.", "effective_dosage": "60 mg Pycnogenol(\u00ae) and 690 mg L-arginine (daily frequency not specified).", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:40.039281+00:00"}
{"study_id": 33743, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol could attenuate ventilator-induced lung injury in rats by reducing inflammatory cytokines and inhibiting NF-\u03baB activation.", "results_summary": "Pycnogenol pretreatment significantly reduced lung injury markers (wet/dry ratio, MPO activity, protein concentration) and inflammatory cytokines (TNF-\u03b1, IL-6, IL-1\u03b2, MIP-2) in BALF, while improving lung histology and inhibiting NF-\u03baB pathway activation.", "population_specificity": "Rats subjected to ventilator-induced lung injury.", "effective_dosage": "30 mg/kg orally once, administered 2 days before injury induction.", "study_duration": "Single dose, 2 days before ventilation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:43.547463+00:00"}
{"study_id": 33742, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol (PYC) could protect against rotenone-induced neurotoxicity in PC12 cells and explore the underlying mechanisms, particularly the NF-\u03baB-iNOS signaling pathway.", "results_summary": "PYC treatment significantly increased cell viability and reduced apoptosis in rotenone-treated PC12 cells in a dose-dependent manner. It also downregulated NF-\u03baB-iNOS signaling, suggesting a protective mechanism against neurotoxicity.", "population_specificity": "PC12 cells (a rat adrenal pheochromocytoma cell line used as a model for neuronal studies).", "effective_dosage": "Not specified (dose-dependent effects observed but exact amounts not provided).", "study_duration": "Not specified (pretreatment and treatment durations not detailed).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:43.961928+00:00"}
{"study_id": 33744, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the biological actions of Pycnogenol in treating metabolic syndrome and related disorders, including obesity, dyslipidaemia, diabetes, and hypertension.", "results_summary": "Pycnogenol demonstrated strong antioxidant, anti-inflammatory, and vasodilator effects, improving blood glucose levels in diabetes, reducing blood pressure in hypertension, and enhancing lipid profile, renal, and endothelial functions in metabolic syndrome. Clinical studies supported its efficacy across multiple components of metabolic syndrome.", "population_specificity": "People with metabolic syndrome, diabetes, mild to moderate hypertension, and related disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:45.908054+00:00"}
{"study_id": 33746, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anticancer effects of Pycnogenol in MC-3 human mucoepidermoid carcinoma (MEC) cell line.", "results_summary": "Pycnogenol significantly decreased cell viability and induced caspase-independent apoptosis, including translocation of apoptosis-inducing factor into the nucleus and enhanced Bak protein stability.", "population_specificity": "MC-3 human oral mucoepidermoid carcinoma (MEC) cell line.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:46.208051+00:00"}
{"study_id": 33745, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the apoptotic effects of Pycnogenol and its constituents on human fibrosarcoma cells (HT1080) and compare its efficacy to its main components.", "results_summary": "Pycnogenol induced significant apoptotic cell death in HT1080 cells ex vivo, outperforming its individual constituents (catechin, epicatechin, taxifolin). Microarray analysis revealed gene expression changes linked to apoptotic pathways.", "population_specificity": "10 healthy adults (6 females, 4 males, mean age 24.8 \u00b1 6 years).", "effective_dosage": "Single dose of 300 mg Pycnogenol orally.", "study_duration": "Single administration, plasma samples taken 6 hours post-intake.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:46.895203+00:00"}
{"study_id": 33747, "supplement_id": 1491, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Prelox\u00aeR, containing Pycnogenol\u00ae, improves male fertility by enhancing sperm quality and e-NOS activity.", "results_summary": "Prelox\u00aeR significantly improved sperm volume, concentration, motility, vitality, morphology, and Fertility Index compared to placebo, with elevated e-NOS activity and no reported adverse effects.", "population_specificity": "50 subfertile men", "effective_dosage": "2 tablets twice daily", "study_duration": "1 month per treatment phase (with washout and crossover)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:48.101147+00:00"}
{"study_id": 33748, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol, as an NF-\u03baB inhibitor, could improve dysmenorrhea when used alongside a low-dose oral contraceptive.", "results_summary": "Pycnogenol significantly reduced pain scores (from 9 to 2) and bleeding days compared to the contraceptive alone, with 27% of patients becoming pain-free. The difference between groups was statistically significant (P<0.0001).", "population_specificity": "24 women with severe dysmenorrhea using a specific oral contraceptive (15 \u03bcg ethinyl estradiol + 60 mg gestodene).", "effective_dosage": "100 mg Pycnogenol (Flebon\u00ae) continuously.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:49.440088+00:00"}
{"study_id": 33749, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Pycnogenol, alone and in combination with TTFCA, on atherosclerosis progression and oxidative stress in low-risk asymptomatic subjects with carotid or femoral stenosing plaques.", "results_summary": "Pycnogenol 100 mg/day significantly reduced plaque progression and cardiovascular events compared to controls, with the best results seen in combination with TTFCA. Oxidative stress was also reduced in all Pycnogenol groups, particularly in the combined treatment group.", "population_specificity": "Low-risk asymptomatic subjects aged 45-60 with carotid or femoral stenosing plaques (>50-60%) and no conventional risk factors.", "effective_dosage": "50 mg/day or 100 mg/day of Pycnogenol, with some groups also receiving 100 mg/day of TTFCA.", "study_duration": "42 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:54.081311+00:00"}
{"study_id": 33750, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Pycnogenol\u00ae on HCV replication, including its potential synergistic effects with standard antiviral agents and its activity against resistant HCV mutants.", "results_summary": "Pycnogenol\u00ae demonstrated antiviral effects without cytotoxicity at doses up to 50 \u03bcg/mL, showed synergistic effects with interferon-alpha and ribavirin, and inhibited HCV replication in both wild-type and telaprevir-resistant replicon cells. It also reduced reactive oxygen species in HCV replicon cell lines and suppressed HCV replication in infected chimeric mice.", "population_specificity": "HCV replicon cells and HCV-infected chimeric mice.", "effective_dosage": "Up to 50 \u03bcg/mL.", "study_duration": "Not specified.", "interactions": "Synergistic effects with interferon-alpha and ribavirin; additive effects with telaprevir.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:54.255426+00:00"}
{"study_id": 33752, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Pycnogenol's protective effects on oxidative stress, inflammation, and DNA damage in sepsis-induced rats.", "results_summary": "Pycnogenol reduced oxidative stress markers (MDA, GSH, SOD, GPx), lowered TNF-\u03b1 levels, and decreased DNA damage in sepsis-induced rats. It also improved antioxidant status and DNA repair capacity.", "population_specificity": "Wistar albino rats with sepsis induced by cecal ligation and puncture.", "effective_dosage": "100 mg/kg intraperitoneally.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:54.757821+00:00"}
{"study_id": 33751, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol could inhibit alveolar bone resorption and osteoclast differentiation in a rat model of periodontitis induced by P. gingivalis.", "results_summary": "Pycnogenol significantly reduced alveolar bone resorption, inhibited P. gingivalis viability, prevented bacterial adhesion and invasion in epithelial cells, and suppressed osteoclast formation and survival.", "population_specificity": "Rats with induced periodontitis.", "effective_dosage": "0.025% (w/w) in diet for in vivo; 1-100 \u00b5g/ml for in vitro.", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:54.807537+00:00"}
{"study_id": 33753, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Pycnogenol (PYC) could alleviate depression-like behavior in mice induced by chronic corticosterone (CORT) exposure.", "results_summary": "PYC supplementation significantly reduced immobility time in CORT-treated mice, suggesting it may mitigate CORT-induced stress through radical scavenging activity. The study indicates PYC has potential antidepressant-like effects in this model.", "population_specificity": "CORT-treated mice (animal model)", "effective_dosage": "0.2 mg/mL in drinking water (oral administration)", "study_duration": "20 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:55.697664+00:00"}
{"study_id": 33754, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether Pycnogenol supplementation improves psoriasis management outcomes and reduces the need for standard treatments.", "results_summary": "Pycnogenol supplementation led to more pronounced reductions in affected skin areas, severity scores, and oxidative stress compared to standard management alone. It also improved skin moisture, quality of life, and reduced treatment time and costs.", "population_specificity": "Patients aged 30-45 with moderate/severe plaque psoriasis (PASI score \u226510 and 10-49% involved body area).", "effective_dosage": "150 mg/day (50 mg three times daily).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:57.194324+00:00"}
{"study_id": 33740, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Pycnogenol on bone mineral density, trabecular microarchitecture, and bone metabolism in ovariectomized rats.", "results_summary": "Pycnogenol (40 mg/kg) significantly improved bone mineral density, reduced bone resorption biomarkers, and restored trabecular microarchitecture in ovariectomized rats compared to untreated controls.", "population_specificity": "Ovariectomized Sprague-Dawley rats", "effective_dosage": "40 mg/kg by oral gavage", "study_duration": "9 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:10:58.750411+00:00"}
{"study_id": 33757, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Pycnogenol on airway inflammation using an allergic asthma model and RAW264.7 cells.", "results_summary": "Pycnogenol reduced inflammatory markers (IL-1\u03b2, IL-6, IL-4, IL-5, IL-13, IgE) and nitric oxide production, attenuated airway inflammation and mucus hypersecretion, and modulated the expression of iNOS, MMP-9, and HO-1 proteins.", "population_specificity": "OVA-induced allergic asthma model (in vivo) and LPS-stimulated RAW264.7 cells (in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:03.676508+00:00"}
{"study_id": 33758, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if a low daily dosage of 50 mg Pycnogenol could effectively lower oxidative stress in healthy cigarette smokers.", "results_summary": "Pycnogenol significantly reduced reactive oxygen metabolites (d-ROM values) by 25.3% after 2 weeks and maintained lower levels compared to placebo throughout the 8-week treatment. Biological antioxidant potential (BAP) also increased in the Pycnogenol group but dropped after cessation, while placebo values remained unchanged.", "population_specificity": "Healthy cigarette smokers", "effective_dosage": "50 mg daily", "study_duration": "8 weeks of supplementation, followed by 2 weeks of cessation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:03.880177+00:00"}
{"study_id": 33756, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the PKA-dependent inhibitory effect of Pycnogenol on lipolysis and its potential as a weight loss agent in obese mice and primary mouse adipocytes.", "results_summary": "Pycnogenol supplementation reduced body weight gain, visceral fat mass, serum and hepatic triglycerides, and total cholesterol while increasing HDL-cholesterol. It also promoted lipolysis in adipocytes via cAMP-dependent PKA activation, increasing HSL and reducing perilipin A levels.", "population_specificity": "Obese (ob/ob) mice and primary mouse adipocytes.", "effective_dosage": "30 mg/kg in mice; 100 \u03bcg/mL in primary adipocytes.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:04.027741+00:00"}
{"study_id": 33759, "supplement_id": 1491, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the biological profile and clinical efficacy of Pycnogenol in treating chronic venous insufficiency (CVI) and related venous disorders.", "results_summary": "Pycnogenol demonstrated strong antioxidant, anti-inflammatory, and vasodilator effects, reducing leg edema in CVI, lowering deep vein thrombosis incidence during long flights, and enhancing healing of venous ulcers and hemorrhoids. Clinical studies supported its efficacy in both oral and topical applications.", "population_specificity": "Patients with chronic venous insufficiency, deep vein thrombosis, post-thrombotic syndrome, long-haul flight-related leg edema, venous ulcers, and acute hemorrhoids.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:04.089539+00:00"}
{"study_id": 33761, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Pycnogenol, among other phytonutrients, could extend the lifespan of male F1 hybrid mice.", "results_summary": "Pycnogenol, in combination with quercetin and taxifolin, increased body weight but did not significantly extend lifespan in the mice. The study suggests that isolated phytonutrients like Pycnogenol may not be effective longevity therapeutics.", "population_specificity": "Male F1 hybrid mice (12 months old at intervention start)", "effective_dosage": "Not specified", "study_duration": "Not specified (intervention began at 12 months of age)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:05.863420+00:00"}
{"study_id": 33760, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the neuroprotective effects of Pycnogenol (PYC) after traumatic brain injury (TBI) and assess its therapeutic potential when administered at different post-injury time points.", "results_summary": "PYC treatment significantly reduced oxidative stress (TBARS) and protected synaptic proteins in both the cortex and hippocampus after TBI, demonstrating neuroprotective effects with a therapeutic window of at least 4 hours post-injury. The benefits were observed across all tested doses (1, 5, and 10 mg/kg) and treatment delays (15 min, 2 h, or 4 h post-injury).", "population_specificity": "Young adult male Sprague-Dawley rats with moderate/severe cortical contusion.", "effective_dosage": "1, 5, or 10 mg/kg, single intravenous injection.", "study_duration": "Single dose, outcomes assessed at 96 hours post-TBI.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:06.663036+00:00"}
{"study_id": 33762, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuroprotective potential of Pycnogenol in a mouse model of Parkinson's disease, focusing on its effects on oxidative stress, inflammation, and neurodegeneration.", "results_summary": "Pycnogenol significantly reduced MPTP-induced neuroinflammation, neurodegeneration, and behavioral impairments in mice, suggesting it protects dopaminergic neurons from toxicity. The study found marked reductions in oxidative stress, inflammatory markers, and improved motor coordination with Pycnogenol treatment.", "population_specificity": "MPTP-induced Parkinsonism mouse model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:07.333665+00:00"}
{"study_id": 33755, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Pycnogenol, alone or combined with TECA, on atherosclerosis progression and oxidative stress in low-risk asymptomatic subjects with non-stenosing plaques.", "results_summary": "Pycnogenol 100 mg/day reduced plaque progression and oxidative stress, with the best results seen when combined with TECA. The control and aspirin groups showed significantly higher plaque progression rates.", "population_specificity": "Low-risk asymptomatic subjects aged 45-60 with non-stenosing carotid or femoral plaques and no conventional risk factors.", "effective_dosage": "50 mg/day or 100 mg/day of Pycnogenol; 100 mg/day of TECA in combination.", "study_duration": "30 months with six-monthly follow-ups.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:08.683296+00:00"}
{"study_id": 33763, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of Pycnogenol and Vitamin E in treating Chemotherapy-Related Oral Mucositis (ChROM) in children.", "results_summary": "Pycnogenol showed significant improvement in oral mucositis compared to the control group, with results comparable to Vitamin E, but it was not effective for severe mucositis (grade 4).", "population_specificity": "Children aged 6-15 years with Chemotherapy-Related Oral Mucositis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:11.619597+00:00"}
{"study_id": 33765, "supplement_id": 1491, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the protective effects and mechanism of Pycnogenol (PYC) on hyperglycemia, inflammatory markers, and oxidative damage in a type I diabetes rat model.", "results_summary": "PYC significantly reduced hyperglycemia, inflammatory markers, and oxidative damage while improving insulin levels and hepatic glycogen in diabetic rats. It also showed protective effects on liver and pancreas histology.", "population_specificity": "Streptozotocin-induced diabetic rats (type I diabetes model).", "effective_dosage": "10 mg/kg body weight.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:11:12.645494+00:00"}
